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Methyl coumalate is a bio-renewable material derived from malic acid. In the first 
chapter, we focused on the Diels-Alder reaction of methyl coumalate with a variety of 
dienophiles, including enamines, magnesium salts of indoles and hydroxyquinones. Some 
provided the bicyclic lactone intermediates, which could be further transformed into 
aromatic esters by acid/base catalyzed ring opening reactions. Others went through a 
Diels-Alder/retro Diels-Alder cascade and the carbon dioxide was extruded, affording the 
corresponding products. As a result, isophthalates, naphthalates and anthraquinone 
derivatives were successfully synthesized according to this strategy. The natural product 
Tomichaedin was also synthesized in over 40% yield. 
 In the second chapter, we have developed a method to in situ generate 
nitroquinone, and a variety of nucleophiles were tested for the conjugate addition. 
Substituted nitroquinones can be synthesized in moderate yield via a 1,4-addition – 
tautomerization cascade. Nucleophiles including indoles, electron rich aromatics and 
heterocycles all showed good reactivity. Additionally, a divergent synthesis towards 




CHAPTER 1.    PYRONE CONTAINING COMPOUNDS IN ORGANIC 
SYNTHESIS 
1.1.      Chapter 1. Introduction  
1.1.1. Natural Products Bearing a 2-Pyrone Motif 
Pyrones are a family of cyclic organic compounds containing an oxygen atom in a 
6-membered ring system. The isomer with a lactone unit is known as 2-pyrone, while the 
oxygen atom at the 4-position is named as 4-pyrone (Figure 1.1). Both pyrones share the 
chemical properties of unsaturated alkene together with aromatic ring due to the unique 
unsaturated lactone structure1,2. 
 
Figure 1.1 Structure of pyrones 
Pyrone containing compounds are highly abundant in natural products. The 
biosynthetic pathway of pyrones was studied in recent years. The most accepted pathway 
is via the polyketide intermediates3. For example, the biosynthesis of 4-hydroxypyrones 
was revealed in Scheme 1.1. Starting with preformed long-chain fatty acyl-CoA 
thioesters, malonyl-CoA, as an extender unit, was added to the substrate twice, forming 
the triketide thioester intermediate. Cyclization via a Claisen-condensation mechanism 
followed by elimination of S-CoA afforded the 4-hydroxy pyrones. Other pathways for 
the generation of 2-pyrones were proposed, resulting in diverse structures of the ring or 




Scheme 1.1 Biosynthetic pathway of 4-hydroxy-2-pyrones 
Some natural products with pyrone subunits showed excellent biological activities, 
as listed in Figure 1.2. Neurymenolide A, which was isolated from Fijian red macroalga, 
Neurymenia fraxinifolia, was found to have moderate cytotoxicity against cancer cell 
lines in vitro5. Moreover, Arisugacin A, was proved to show great potential in the 
treatment of Alzheimer’s disease6. Other structure also provided good properties for 
future uses in the drug industry for their anti-fungal, anti-HIV or anti-tumor properties7. 
 
 Figure 1.2 Bioactive pyrone containing natural products 
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1.1.2. Biorenewable Chemicals and Methyl Coumalate 
Biorenewable chemicals are in general divided into two parts by their production 
methods (Scheme 1.2). One could be obtained via a chemical pathway, where the 
production of hydroxymethylfurfural (HMF) is representative. HMF can be chemically 
produced from Jerusalem artichoke by FeCl2/H2O2 catalyzed dehydration process
8, or by 
the treatment of grape biomass extract with CrCl3/HCl in ionic liquid
9. On the other hand, 
an alternative pathway is through a pure biocatalysis approach, where the production of 
methanol/ethanol by enzymatic catalysis from soybean is an example for demonstration 10. 
Other types of biodiesel can be manufactured from similar biocatalysis conversion, using 
different plants and enzymes as feedstock11.  
 
Scheme 1.2 Pathways of production for bioreneable chemicals 
Shanks and Dumesic developed the concept of combining chemical and biological 
catalysis for producing sustainable chemicals in 201411, as briefly described in Figure 1.3. 
Common sugars (C5 and C6 sugars) can be produced from biomass feedstock, and 
further selectively transformed into highly functionalized shorter carbon chain molecules 
(platform molecules) through fermentation by different bacteria in a biological catalysis 
pathway. The platform chemicals above are suitable for catalytic upgrading, and they are 
thought to be useful synthetic starting materials for various organic compounds. Such a 
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strategy provided a connecting bridge for both biological and chemical transformations, 
leading to a broader possibility for biorenewable and sustainable chemical productions.  
 
Figure 1.3 Bioprivileged molecules and biorenewable chemicals 
Coumalic acid, which can be chemically synthesized from a biorenewable 
feedstock malic acid, is recognized as one of the bioprivileged molecules. In 2014, Kraus 
group has developed the method shown in Scheme 1.3, where malic acid can dimerize to 




Scheme 1.3 Synthesis of coumalic acid from malic acid 
The mechanism of this transformation was also proposed, as shown in Scheme 1.4. 
The first step is under acidic condition, malic acid loses CO and H2O in situ, forming the 
unstable intermediate 3-hydroxyacrylic acid, which further dimerizes and loses water in 
an acid catalyzed aldol reaction. The function of sulfuric acid in this process is not only 
as a solvent, but also works as a catalyst and dehydration reagent. As a result, the final 
product coumalic acid was obtained as a solid. 
 
Scheme 1.4 Mechanism of synthesizing coumalic acid 
As the methyl ester of coumalic acid, methyl coumalate 1 is also considered to be 
a biorenewable chemical. Methods for converting methyl coumalate into other high-value 
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chemicals were developed, including [4+2] type cyclization and a [2+2] type 
cyclization15. Intermolecular [2+2] photocycloaddition was reported by the Shimo14a 
group in 1991, where 2-acetonaphthone was used as a photosensitizer. The 
photochemical reaction between electron rich olefins with 1, as well as other pyrones was 
successfully achieved, leading to tricyclic cyclobutane products 2a and 2b as a mixture of 
diastereomers in low yield. Baran group14b has reported an intramolecular 4π 
electrocyclization strategy of methyl coumalate 1, followed by hydrogenation to 
cyclobutane dicarboxylate 4. It was obtained as a single diastereomer, which was further 
used as a precursor of the core structure of Piperarborenine D (Scheme 1.5). 
Unfortunately, the NMR of synthetic Piperarborenine D did not match the NMR data of 
the one that was isolated. 
 Scheme 1.5 Photo induced [2+2] cyclization reactions of 1  
Methyl coumalate 1 as an electron-deficient pyrone could also function as an 
electrophile for conjugate addition, where the 6-position is considered to be the most 
active site. The Dechoux group did studies on the stereoselectivity and kinetics when 
reacting with Grignard reagents, where they found the nature of the Grignard (alkynyls, 
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alkenyls or alkyls) is critical to control the Z/E selectivity, and the effect could be 
explained as kinetic control versus thermodynamic control16. The resulting ring opened 
alkenes are synthetically useful materials that are rich in functionality.  
Exclusive studies were done in the area of Diels-Alder type reactions between 
methyl coumalate with a variety of dienophiles. Generally, the mechanism is the [4+2] 
cycloaddition followed by extrusion of carbon dioxide, affording aromatic acids or esters, 
as shown in Scheme 1.6. The bicyclic intermediate is not isolated and the loss of CO2 is 
considered to be facile for this tandem process. 
 
Scheme 1.6 General mechanism for Diels-Alder reaction of 1   
Synthesis of substituted benzoates via the strategy mentioned above was firstly 
reported by Ziegler group in 198717a. Methyl propiolate and ethoxyethyne were used as 
the dienophile and benzene was used as the solvent. The reaction was carried in a sealed 
tube at high temperature, and the result indicated that electron-deficient acetylenes were 
favored in this transformation (98% yield of 6a and 6b combined). An improved work 
was published by Leonard at 200717b. In his paper, propargyl alcohols were used as 
dienophiles, reacting with substituted pyrones at 180°C in a sealed tube. They indicated 
that the addition of 50% of citric acid would enhance the yield when acetyl or TBS 
protected propargyl alcohols were used, presumably via a hydrogen bonding interaction 
between the pyrone and citric acid. Such interactions decreased the electron density in the 
pyrone ring, thus making it more reactive towards electron rich alkynes. Trisubstituted 
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benzoate 7 was successfully synthesized in 76% yield. There was a significant increase of 
yield when reacting pyrones with other substituted alkynes that had either electron- 
donating groups or withdrawing groups (Scheme 1.7). 
 
Scheme 1.7 Synthesis of substituted benzoates 
In 2011, Kraus18a introduced the Diels-Alder reaction of methyl coumalate with 
olefins. As shown in Scheme 1.8, the mechanism involving alkenes resembled the 
mechanism involving alkynes. As described in Scheme 1.8, Diels-Alder cyclization of the 
two components followed by extruding CO2, generated a cyclohexadiene in situ. Ten 
percent of Pd/C was added to the reaction mixture as a dehydrogenation reagent to give 
substituted benzoates. Because unactivated olefins were employed in this reaction, both 
para and meta-substituted products were expected to be observed. However, in this case, 
the only isolated benzoates were para-substituted. Even though the reason for the 
remarkable selectivity was not rationalized in this paper, a new method for synthesizing 
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4-alkylbenzoates was introduced. A DFT computational study by Shanks18c in 2018 
revealed the selectivity. The energy barrier for retro Diels-Alder reaction (180 kJ/mol) is 
much higher than the forward reaction (147 kJ/mol), and this suggested the absence of 
the retro D-A process. The energy barriers for the formation of 8a and 8b from methyl 
coumalate are 74 kJ/mol and 77 kJ/mol, respectively, which indicated the intermediate 
bicyclic lactone 8a is energetically more favored in the Diels-Alder step. The rate 
constant analysis also provided evidence that formation of 8a is roughly 5 times faster 
than 8b.  
 
Scheme 1.8 Synthetic and kinetic studies on Diels-Alder reaction of 1 with 
olefins 
As illustrated in Scheme 1.8, another computational study from Shanks in 2017 
suggested that the rate-limiting step for this transformation is the decarboxylation step18b. 
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1H NMR was used for real-time tracking of the reaction, and notably, no accumulation of 
9a was observed when the dehydrogenation reagent Pd/C was added to the mixture. This 
evidence suggested that the rate of dehydrogenation is much more rapid than the rate of 
Diels-Alder reaction.  
Besides using Pd/C as the catalyst to gain aromaticity, other approaches showed a 
more convenient pathway towards the Diels-Alder reaction of methyl coumalate. Liao in 
200019c, showed that the reaction could be stopped at the lactone intermediate. As listed 
in Scheme 1.9. electron-deficient pyrones reacted readily with 2-methoxyfuran at a lower 
temperature (r.t. to 90°C) in methanol, affording tricyclic lactone 10 in moderate yield. 
The electron-rich pyrones were unreactive. Semiempirical calculations (AM1 and PM3) 
suggested that these are inverse electron demand Diels-Alder reactions, and the excellent 
stereoselectivity was explained by the secondary orbital interaction during the transition 
state. Attempts to further transform the tricyclic lactone 10 to a substituted benzoate were 
successful by refluxing the reaction mixture for 50 hours in methanol, resulting in a 47% 
yield of the benzoate 11. This finding was evidence of the cyclic lactone intermediate 
was stable and extrusion of carbon dioxide was the rate-determine step for aromatization. 
 Scheme 1.9 Approach to benzoate from methoxyfuran 
 In 2013, Kraus19a introduced a methodology for isophthalates using vinyl ethers 
and methyl coumalate. As shown in Scheme 1.10, bifunctional aromatic systems 12 were 
synthesized when treating methyl coumalate 1 with 3,4-dihydro-2H-pyran at 200°C. The 
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mechanism was proposed to be a cycloaddition/retro Diels-Alder/elimination followed by 
alcohol protection cascade. A ketal could also be used as the reactant for this type of 
transformation.  The ketal (2,2-dimethoxypropane) was considered to be a precursor for 
vinyl ether. 
 
Scheme 1.10 Synthesis of benzoates using vinyl ether or ketal 
A few years later, an improved methodology by Kraus19b was introduced, where 
they not only overcame the factor of high temperature, but also took advantage of the 
lactone ring opening reaction as a method for synthesizing isophthalates. In the paper, 
they pointed out that the bicyclic lactone from methyl coumalate 13 was stable under 
100 °C.  Therefore, the Diels-Alder reaction with vinyl ether was performed in 
acetonitrile at 75 °C for one day. Different catalysts were tested for ring opening, and the 
best result was obtained using 5 mol% of PTSA in methanol for 18 hours. Because 
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methanol was used as the solvent, the corresponding isophthalates 14 were isolated as 
methyl esters (Scheme 1.11). 
 
 Scheme 1.11 Strategy towards isophthalates 14 
1.1.3. Polyethylene Terephthalate and Polyethylene Naphthalate 
Polyethylene terephthalate (PET) is considered to be a basic material in the 
polymer industry. The synthesis of PET is through polymerization reaction from two 
basic feedstocks, terephthalic acid and ethylene glycol. PET is one of the most common 
plastic materials, and it is used in food distribution, beverage bottling, housing appliances, 
electronics and other fields. The easily obtained and low-cost starting monomers have 
made PET one of the important units in the thermoplastic industry since 197720.  
Although multiple renewable methods for the production of terephthalic acid were 
developed, the most acceptable and popular way for its production is still via the catalytic 
oxidation from para-xylene, which was isolated by fractional distillation originally from 
the crude oil21 (Scheme 1.12). Such a non-sustainable process has continued for decades, 
and still growing towards bigger markets. 
The reasons that PET is popular is because of its great physical and chemical 
properties. The food packaging industry requires a material that has barrier properties that 
can prevent small molecules from diffusing into the container, and PET was recognized 
as a good candidate. The great barrier properties of PET, which arise from the nature of 
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small specific free volume in the polymer, makes it hard for small molecules such as O2, 
CO2 and H2O to diffuse through the membrane
22. For housing appliances, thermal 
stability is essential. PET has high thermal-oxidative degradation temperature, with an 
apparent activation energy of 117kJ/mol in air according to the experimental differential 
scanning calorimetry data23. Beverage bottling requires a plastic that has low amounts of 
volatile substances that migrate into liquid. PET shows great performance with very low 
overall migration. Under heating condition at 150 °C, 260 °C and 270 °C from 5 to 60 
minutes, a 15-fold increase of the second series alicyclic oligomers were observed in low 
concentration24, which indicates that PET is well suited for high-temperature 
food/beverage contact applications.  
 
 Scheme 1.12 Synthesis of PET 
 However, there are also disadvantages of PET. The low glass transition 
temperature and low natural degradation rate make it hard to recycle, and causing a huge 
pollution problem in the environment. According to the data in 2004, the consumption of 
plastic is 38 million tons per year in Western Europe25 and over 60% of which are 
disposed of to landfills26. The time it takes to decompose is over hundreds of years. 
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Plastic recycling is important for two main reasons: firstly, to reduce the waste and 
pollution of the environment, and secondly, to lower the production cost by using 
regenerated materials27. The challenges we are currently facing is that the used PET does 
not meet the minimum requirements to be reprocessed28, including viscosity coefficient, 
melting temperature, and water content. For this reason, the recycling quantities of PET 
remain at the level of less than half million ton per year for decades, but the waste 
quantities dramatically increased in the United States28. Although numerous methods for 
recycling PET were reported, including processing by resin, compatibilization or physical 
blending29, such methods failed to overcome the problems due to the nature of PET.  
 To solve the recycling problem, polyethylene naphthoate (PEN), which has 
superior physical properties is starting to gain attention in recent years. The larger 
conjugation provided by the naphthalene ring – gives PEN a higher glass transition 
temperature and better physical properties (Table 1.1)30. Higher stability makes PEN a 
better material for practical uses and easier for the recycling process. The market of PEN 
has increased to 200 million USD in 2018 and still growing.  It is mostly used in food 
packaging, electronics and rubber tires. The rising market makes PEN a potential 
replacement for PET. There are also studies reported the blended mixture of the two 
polymers has improved properties. For example, Jabarin31 claimed that an increase of 
glass transition temperature was observed when the fraction of PEN was increased in the 
blend, and multiple melting peaks were also scanned. Regarding the optical properties, 
Takahashi32 published an exciting result in 2013, showing that a 1:1 ratio PEN/PET blend 
has a superior UV absorption comparing to pure PEN or PET. The results above indicate 
that it is possible to combine the two polymers as a better material. 
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Table 1.1 Comparison of PET and 2,6-PEN 
 PET PEN 
Density (kg/m3) 1320 1360 
Glass Transition Temperature (°C) 120 160 
Tensile Strength (20°C, GPa) 14 23-30 
Tensile Modulus (20°C, GPa) 1.0 1.2 
Crystallinity 40 50 
 In consideration of the huge potential of PEN, it would be environmentally 
friendly if one could be synthesized by a sustainable route. The synthesis of PEN used the 
naphthalene diester and ethylene glycol as two monomers. According to the report by 
Lillwitz, naphthalene diester was mostly obtained from crude oil distillates. As shown in 
Scheme 1.13, after catalytic oxidation or reformation, naphthalene-2,6-dicarboxylic acid 
can be synthesized industrially33. 
 
 Scheme 1.13 Synthesis of naphthalene-2,6-dicarboxylic acid 
 Extensive studies have been done for both physical and chemical properties of 
PEN, including gas diffusion rate, hot compaction, laser nanopattern, fracture behavior 
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and electronic conduction34-38. These results illustrate that the potential of PEN is still 
under exploration. 
1.1.4. Indole Mediated Cycloaddition Chemistry 
Indole is recognized to be one of the most important privileged scaffolds in the drug 
industry. The unique fused pyrrole ring provided a binding site for peptides and enzymes, 
which provide numerous opportunities in discovering new drugs39. Indole alkaloids are 
widely found in nature as bio-active compounds which can be isolated from plants, 
insects and other creatures. A good number of the natural indole alkaloids that have bio-
activities (Scheme 1.14) were used in the drug industry. The simple structure 5-
hydroxytryptophan, a derivative from an essential amino acid tryptophan, can be used as 
a dietary supplement as an antidepressant, anxiolytic and sleep aid40.  Ajmalicine (also 
known as raubasine), a natural indole found in plants, is used as an antihypertensive drug 
against high blood pressure41. Golotimod is a synthetic peptide containing amino acid 
tryptophan. Studies by Suzuki group showed that it is a potential drug candidate for its 
immunostimulanting, antimicrobial and antineoplastic activities42. Reserpine is also used 
to treat high blood pressure and severe mental disorders43. Importantly, atevirdine shows 
an anti-HIV activity in vitro by inhibiting the reverse transcriptase.  A concentration of 1 
nM of atevirdine can inhibit up to 50% of HIV-1 virus replication44. It also inhibits 
completely the formation of syncytia in human T-cell leukemia virus type III infected 
cells at a concentration of 2μM45. Dalavirdine, known as a first generation of non-
nucleoside reverse transcriptase inhibitors, was approved by FDA as the drug for the 
treatment of HIV-146. The complex indole alkaloid vinblastine was used to treat several 
types of cancer, including breast and testicle cancer47. 
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 Scheme 1.14 Bio-active compounds have indole subunit  
Developing new methods towards indole alkaloid synthesis has always been a 
hotspot in the synthetic organic chemistry. Construction of multicyclic fused ring systems 
was exclusively studied, and a number of innovative strategies were reported. Here, a 
series of indole alkaloids that were isolated from Vinca minor leaves that share the 
common ring framework were presented as example. As listed in Scheme 1.15, 
vincadifformine, minovincinine and monovincine are all pentacyclic indole systems48. 
Since structural similar natural products such as vinblastine and vincristine have been 
applied to clinical uses, total synthesis of monovincine type structure has attracted plenty 




Scheme 1.15 Structure of vincadifformine, monovincine and minovincinine 
Attempts towards the total synthesis of minovincine are shown in Scheme 1.16. 
The most traditional way was forming the C ring via a Diels-Alder reaction from the 
common intermediate 15.  Here, 2-vinylindole acted as the diene and reacted with the  
 Scheme 1.16 Approaches towards minovincine 
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enamine in the preformed D ring. Such approaches were well illustrated by Earley (1983), 
Sundaramoorthi (1985), Marko (1986) and Suzuki (1998)49. Another approach, 
introduced by Stephenson in 201450, took advantage of pentacyclic compound 16, under 
the condition of Ir catalyst with TMSCN. Catharanthine fragmentation reaction happened 
and afforded the tetracyclic indole 17, which was transformed to minovincine in a few 
steps. In 2013, Macmillan achieved the first enantioselective total synthesis of 
minovincine in 9 steps51. An organocatalytic Diels-Alder/elimination/conjugate addition 
cascade was introduced using the indole 19 with but-3-yn-2-one to construct the 
tetracyclic framework with high enantioselectivity (ee = 91%). 3 years later, Dixon 
published a divergent synthesis of 5 indole alkaloids including vincaminorine, 
vincadifformine and minovine52. They used a reductive cyclization cascade from a stable 
lactam 18 to a reactive enamine 19 catalyzed by iridium complex. Minovine together 
with vincaminorine were synthesized from the lactam 18 in one step in 83% combined 
yield. The key reaction in the routes presented above was the step to introduce the 
quaternary center on ring B, C and D. 
 Since most of the methods were using 2-vinylindole as the Diels-Alder reaction 
precursor to form the C ring, other approaches were also reported of the C ring formation. 
Buckvall reported an inverse electron demand Diels-Alder reaction where they used the 
magnesium salt of indole as the electron rich dienophile, and reacted with electron poor 
diene, affording the cyclization product tetrahydrocarbazoles53 as illustrated in Scheme 
1.17. They believed this cyclization went through a sequential Michael addition reaction 
mechanism. In a related approach published in 1992, Marko reported the anion of indole 
reacted readily with vinyl acrylates affording 2154. Kraus prepared the substituted 
20 
 
carbazoles from methyl coumalate and 3-chloroindole via a Diels-Alder-extrusion- 
elimination cascade in 201455. A computational study indicated the elimination of HCl 
preceded the loss of carbon dioxide56. Indole or its anion are rarely used in the synthesis 
of indole alkaloids, however, it is still considered to be an efficient approach for some 
target compounds.  
 
Scheme 1.17 Inverse electron demand Diels-Alder reaction 
1.1.5. Anthraquinones and Naphthoquinones 
Anthraquinone and naphthoquinones are important building blocks for both the 
polymer and the pharmaceutical industry. A direct synthesis for such compounds is 
always under exploration. Anthracene diester can be used as a monomer for the 
production of polyethylene anthracenate (PEA), which has a higher glass transition 
temperature and better UV barrier properties compared to polyethylene terephthalate 
(PET)57, as shown in Figure 1.4. The barrier properties could be further improved by 




Figure 1.4 Structures of 2,7-PEA, PET and compounds with quinone subunit 
There are also some natural products containing quinone subunits that have bio-
activities (Figure 1.4). AM 5221 is manufactured by culturing Phialocephala sp., and 
used as a nerve growth factor and accelerator59. Adriamycin (also known as doxorubicin) 
is a chemotherapy medication drug used to treat cancer, including breast cancer, Kaposi’s 
sarcoma, acute lymphocytic leukemia and bladder cancers60. It was first approved for 
medical uses in 1974, and it is still one of the popular anti-cancer drugs nowadays. The 
mechanism for its bio-activity is by interacting with DNA via intercalation, preventing 
the double helix from releasing and thus inhibit the DNA chain replication in cancer 
cells61.  
Tomichaedin is an isomer of the pigment oosporein. It was first isolated from 
laboratory cultures of Oospora colorans by Kogl and van Wessem62. At room 
temperature, tomichaedin is a yellow solid, but it will give a red solution with an alkali 
metal. On zinc-dust distillation it yielded naphthalene and other derivatives63. Although 
their structures vary from each other and have different ring systems, a study by 
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Shigematsu in 1956 indicated that oosporein can be transformed to tomichaedin under 
basic condition64, and the mechanism proposed by Thomson is shown in Scheme 1.1865. 
 Scheme 1.18 Proposed mechanism to from oosporein to tomichaedin 
Oosporein, as a dimer of dihydroxydimethylquinone, is tautomerized to tetraketo 
isomer 23. The unstable tetraketone structure undergoes a β-keto fission reaction to 
release oxalic acid and yield diketonequinone 24. Base catalyzed benzilic acid 
rearrangement of the diketone compound 24 afforded the α-hydroxyacid 25, which 
dehydrates spontaneously to give the unsaturated acid 26. The intramolecular aldol 
condensation reaction between the allylic methyl with ketone afforded the 
dihydroquinone 27, and followed by dehydrogenation to the final product tomichaedin. 
Due to many possible side reactions can happen during the rearrangement, the overall 
yield of such transformation is only about 10%. 
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The first total synthesis of tomichaedin was also reported by Thomson in 196065, 
where they used 2,6-dimethylnaphthalene as the starting material (Scheme 1.19). 
Oxidation followed by nitration of 2,6-dimethylnaphthalene gave the nitro naphthalic 
acid 28.  
 Scheme 1.19 First total synthesis of tomichaedin  
Esterification of the acid followed by reduction of the nitro group afforded the aminoester 
29.  Coupling with diazotized aniline-2,5-disulphonic acid in water/acetone mixture gave 
the azo dye as an intermediate, which was immediately reduced by zinc dust yielded the 
naphthodiamine compound 30. The transformation to naphthoquinone 31 was achieved 
by the oxidation of diamine 30 by iron (III) chloride. The hydroxy group was installed via 
hydrogen peroxide epoxidation reaction, followed by hydrolysis using cold concentrated 
sulfuric acid. The last step was hydrolysis for the methyl ester 32 by reflux in dilute 
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acetic acid for 1 hour, and tomichaedin was successfully recrystallized from the mixture 
as a yellow crystal. The overall yield was not reported. 
1.2.      Result and Discussion  
1.2.1. Diels-Alder Reaction of Pyrones and Enamines 
Pyrones are commonly used in organic synthesis, especially in cycloaddition 
reactions. The studies of Diels-Alder type transformations of methyl coumalate still have 
limitations. First of all, such reactions require a high temperature to reach the activation 
energy. Second, the bicyclic lactone often extrudes CO2, resulted in loss of a carboxylic 
acid group for further functionalization.  Our goal is to develop a better method for the 
chemical transformation of the sustainable compounds that is scalable in the future. Thus, 
reduced temperatures and faster reaction rates are essential for the Diels-Alder reaction of 
methyl coumalate 1. 
Our initial attempt started with the enamine 33, which is considered to be a 
stronger dienophile than an enol ether. Screening on different solvents showed that the 
bicyclic lactone 34 could be obtained as a stable and separable intermediate. Our best 
result was using DCM as the solvent stirring for 2 hours at ambient temperature, 
compound 34 was isolated in 98% yield as an 8:1 mixture of diastereomers, as shown in 
Table 1.2. The stereoselectivity of the Diels-Alder reaction was believed to be endo 
favored, which was proven by a 1D NOE experiment. The NOE signal was observed 
between the bridgehead hydrogen and the hydrogen of the isopropyl group, which 
indicated the isopropyl group is perpendicular to the cyclohexane ring of major 




Table 1.2 Solvent screening for Diels-Alder reaction of methyl coumalate 
Entry Solvent Time (minutes) Yield (%) a 
1 Toluene 90 87 
2 DCM 90 94 
3 DCM 120 98b 
4 THF 90 75 
5 Diethyl ether 90 74 
6 DMF 90 86 
7 Methanol 90 60 
8 1,4-dioxane 90 63 
a Yields were calculated based on 1H NMR using CH2Br2 as standard. 
b Isolated yield. 
Conversion of the bicyclic lactone 34 to isophthalates 35a and 35b was achieved 
by treatment of potassium carbonate as base, using methanol as the solvent at ambient 
temperature. The products were obtained in 89% combine yield (Scheme 1.20). A 
stronger base such as potassium hydroxide would provide the isophthalates in acid form 




Scheme 1.20 Synthesis of isophthalates 35 
With the condition in hand, other enamines were successfully synthesized as 
substrates. The reaction between methyl coumalate with both alkyl and aryl enamines 
went as expected in good yields, as shown in Scheme 1.21. Substitution at ortho (37d), 
meta (37e) and para (37b) position on the aromatic ring did not affect the reaction. The 
morpholine enamine of isobutyraldehyde was not successful under the same condition. 
Modification of this process finally resulted in a one-pot synthesis of meta-substituted 
isophthalates. The Diels-Alder adduct was not required to be isolated, and it could be  
 
Scheme 1.21 Scope of isophthalates synthesis 
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directly used in the hydrolysis step in basic water/methanol solution. The final product 
isophthalic acid could be simply isolated by filtration after the extraction step. 
Cyclic enamines were tested in this study as well. To our surprise, the reaction 
between methyl coumalate with the morpholine enamine of cyclohexanone under the 
same condition did not afford any cyclic lactone. We believed changing to a stronger 
dienophile will accelerate the transformation. Therefore, the pyrrolidine enamine of 
cyclopentanone was successfully synthesized. However, the reaction of the previous 
enamine with methyl coumalate did not afford the lactone. The only isolated product was 
a 3:1 mixture of diastereomers in 23% yield. The mass spectrum gave the M/Z+ at 195, 
and proton NMR showed the major diastereomer should be a structure that does not have 
aromatic protons. Proton resonances at 7.08 ppm (1H, singlet), 7.03 ppm (1H, quartet), 
and 1.83 ppm (3H, doublet) led to the proposed structure shown in Scheme 1.20. Carbon 
NMR resonances and 207.1 ppm and 166.8 ppm also supported the existence of a ketone 
and double bonds. 1H NOE experiment proved that the major diastereomer was taken the 
E,E conformation, due to the observed NOE signal between the terminal methyl and the 
alkene proton. The mechanism for the formation of 42 is proposed in Scheme 1.22. The 
enamine added to the 6-position of methyl coumalate, leading to the intermediate 39. The 
next step was a lactone ring opening reaction leading to 40 which lost CO2 and provided 
the unstable triene structure 41. Hydrolysis of the enamine 41 afforded the final product 




Scheme 1.22 Proposed mechanism for formation of 42 
Fortunately, the pyrrolidine enamine of cyclohexanone 43b reacted readily with 
methyl coumalate, afforded the desired product 45b via a cyclization/retro Diels-
Alder/elimination cascade without isolation of the lactone. Further improvement in yield 
was achieved using methanol as the solvent. The mechanism was proposed as shown in 
Scheme 1.23. The tricyclic lactone intermediate 44 was hypothesized to be unstable due 
to the unfavorable nonbonded interactions which led to a fast retro Diels-Alder reaction 
to form a more energetically stable diene, followed by elimination of pyrrolidine to 
produce the aromatic compound 45b. A similar substrate was also proved to be 
successful when using the enamine of ethyl 4-oxocyclohexane-1-carboxylate 43a, leading 
to tetrahydronaphthoate 45a as the product in 70% yield at ambient temperature. The 
mild conditions and commercially available starting materials for this transformation 




 Scheme 1.23 Proposed mechanism for tetrahydronaphthoate synthesis 
A goal of this project was to explore a transformation of methyl coumalate to 
high-value chemicals.   We converted tetrahydronaphthoate 45a into the dimethyl 2,7-
naphthalate. The corresponding diacid, a possible monomer for polyethylene naphthoate 
synthesis, is commercially priced at $500/gram. Considering the growing market of PEN, 
it will be important if the dimethylnaphthalate could be synthesized in a sustainable 
manner at a lower price.  
In the dehydrogenation step, the traditional metal catalyzed dehydrogenation was 
unsuccessful (Table 1.3). Diester 45a was refluxed with a catalytic amount of Pd/C or 
Pt/C in different high boiling point solvents, and none of the conditions afforded any 
dehydrogenation product 47, which indicated the high activation energy for this step. The 
literature showed a temperature over 300°C is suitable for this transformation57. 





Table 1.3 Attempts on metal catalyzed dehydrogenation reaction of 45a 
 
Entry Catalyst Solvent Temperature (°C) Result 
1 Pd/C Toluene  Reflux  No Reaction  
2 Pd/C Xylene Reflux  No Reaction  
3 Pd/C Cymene Reflux  No Reaction  
4 Pt/C Xylene Reflux  No Reaction  
5 Pt/C Cymene Reflux  No Reaction  
6 Pt/C Cymene 200 No Reaction  
As shown in Scheme 1.24, radical bromination of 45a at the benzylic position 
using AIBN/NBS system provided the dibromo intermediate 46. The use of 2.05 
equivalents of NBS was found to be critical for this transformation.  The reaction would 
not go to completion if less than two equivalents of NBS was employed, while an excess 
of NBS would result in tribrominated product 48, and would lead to the 
bromonaphthalene 49 in the reaction mixture as a non-separable impurity. The 
elimination of HBr was easily accomplished in one pot by treatment of the reaction with 
excess base (more than 4 equivalents of triethylamine was needed, due to the 
neutralization reaction with hydrobromic acid generated from the previous step), and the 




Scheme 1.24 Dehydrogenation of compound 47 
To achieve the scalable synthesis goal, the first step is to synthesize the Diels-
Alder adduct 45a on a large scale. Fortunately, the yield did not show any significant 
drop when the reaction was run on a hundred-gram scale, and the low exothermic 
transformation made the addition of methyl coumalate less dangerous. The diester 45a 
was obtained in large quantities. The challenge we were facing was the purification 
process from the reaction mixture. Using a silica column chromatography for a large 
quantity of material was impractical in the lab.  A new process of for purification was 
proposed, as abbreviated in Scheme 1.25. Ethyl 4-oxocyclohexane-1-carboxylate was 
treated with pyrrolidine using a Dean-Stark trap, affording the unstable enamine 43a.  
The next step was performed in methanol at ambient temperature. The purification was 
achieved by removal of solvents by distillation and removal of pyrrolidine by acid wash. 
The isolation of unreacted methyl coumalate was accomplished by hexane extraction, 
taking the advantage that the product 45a is soluble in hexane whereas methyl coumalate 
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is not soluble. Excess of starting material was separated by high vacuum distillation, and 
the minor side products were oxidized to a dark solid by pyrolysis at 200°C.  
 
Scheme 1.25 Purification process for large quantity production of 45a  
The process for purification of the dehydrogenation step was shown Scheme 1.26. 
After the reaction was finished, HBr was removed by blowing air into the system for a 
few hours. An excess amount of triethylamine was removed by acid. The naphthoate 47 
was found to be surprisingly soluble in hot hexane, which enabled us to remove the 
succinimide side product via a simple hexane extraction. However, due to the low 
recrystallization efficiency of the naphthoate 47, an additional transesterification step was 
employed, yielded the final product dimethyl 2,7-naphthoate 48 as a white crystal. This 
5-step synthesis process was proven to be workable on a kilogram scale, with an overall 




 Scheme 1.26 Purification process and synthesis of dimethyl 2,7-naphthoate 48 
1.2.2. Diels-Alder Reaction of Pyrones and Indole Anions 
 Based on the good results of the Diels-Alder reaction between methyl coumalate 
and enamines, we decided to extend the scope of this reaction. Indole is a special 
aromatic system that has a nitrogen atom in the five membered ring. The aromaticity of 
indole lowered its nucleophilicity comparing to the regular enamine. However, 
experiments showed that the 3-position of indole is still nucleophilic, and it is able to 
react with electrophiles in conjugate addition or nucleophilic substitution reactions.  
Initially, the Diels-Alder reaction between methyl coumalate 1 and indole 46a 
was tested in THF solution (the indole anion was pre-formed by treating indole with 
isopropylmagnesium chloride). The tetracyclic lactone adduct was formed in situ as a 
mixture of isomers, which could undergo a retro-Diels-Alder process at room temperature 
to give dihydrocarbazole acid 47a in low yield. Changing the base to magnesium bromide 
or magnesium iodide provided a slight improvement in yield of 47a, but as a crude 
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mixture of the desired product together with some cycloaddition adducts. The best result 
was obtained by using methyl magnesium iodide as the base, and the solvent was the 1:1 
mixture of THF and diethyl ether at 0°C. The cycloaddition/lactone ring opening product 
47a was obtained in 75% yield in one pot (Scheme 1.27).  
 
 Scheme 1.27 Synthesis of dihydrocarbazole 47 
 To our surprise, the reaction of 3-methylindole 46b with methyl coumalate 1 
under the same condition stopped at the tetracyclic lactone step. After working up and 
recrystallization, the lactone 48 was obtained as a single diastereomer in 67% yield. The 
endo-structure was assigned by 1H NOE experiment, where a NOE signal was observed 
between the methyl ester and the vinyl hydrogen, as well as between the methyl group 
(on the 3-position of indole) and the vinyl hydrogen.  
The tetracyclic lactone 47b was not stable at room temperature, and would 
undergo a spontaneous retro-Diels-Alder reaction to the starting materials slowly. 
Experiments towards the ring opening adduct 47b were carried under the treatment of 
cyclic lactone 48 with hydrochloric acid in THF/water. Unfortunately, the lactone ring 
did not open under this condition and there was no desired product formed. Other 
attempts included treating 48 with trifluoroacetic acid, but no product was observed at -
20°C. Eventually, we found that dilute TfOH acid in THF at -20°C can successfully 
catalyze the ring opening process, and the cyclic lactone 48 was converted to 




Scheme 1.28 Synthesis of methylcarbazole 47b  
The reaction of 3-allylindole 46c with methyl coumalate 1 gave the tetracyclic 
lactone 49 in 43% combined yield as a 2:3 mixture of diastereomer (endo and exo) under 
the condition above. Lactone 49 could be stored at room temperature for a short period of 
time, and it could be converted to allylcarbazole 47c via the TfOH acid catalyzed ring 
opening reaction in 31% yield (Scheme 1.29). 
 
 Scheme 1.29 Synthesis of allylcarbazole 47c 
1.2.3. Diels-Alder Reaction of Pyrones and Hydroxyquinones 
 With the previous results in hand, we decided to apply our strategy targeting the 
synthesis of anthracene diester 49 from anthraquinone 48, which could potentially derive 
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from methyl coumalate 1 and benzoquinone 50 in a one-pot process (Scheme 1.30). Such 
methods will provide a direct synthesis of tunable monomer for polyethylene 
anthracenate (PEA) in a sustainable manner. 
 
 Scheme 1.30 Retrosynthetic analysis of anthracene diester 49 
 Our synthesis started with methyl coumalate 1 with substituted benzoquinones, as 
shown in Table 1.4. Quinones 50a-d were commercially available or could be 
synthesized in one or two steps from benzoquinone. The Diels-Alder reaction between 1 
and quinones seemed to requires higher activation energy. Under thermal conditions, 
there was no product observed from the reaction crude even at an elevated temperature 
(200°C). After evaluating solvents and conditions, we found that 50c was the only 
reactive compound. However, the addition of base was essential for this reaction to 
proceed. Our best result was obtained by treating with a catalytic amount of triethylamine 





Table 1.4 Screening for optimal conditions 
 
Entry Quinone Solvent Temperature Base Result 
1 50a toluene 160°C - No reaction  
2 50a xylene 200°C - No reaction 
3 50b xylene 160°C - No reaction 
4 50b cymene 200°C - No reaction 
5 50c toluene reflux - No reaction 
6 50c DCM reflux - No reaction 
7 50c CH3CN 80°C - No reaction 
8 50c CH3CN 80°C NEt3 67% 
9 50c CH3CN (Ar) 80°C NEt3 98% 
10 50c DMF 80°C NEt3 <5% 
11 50c DMSO 80°C NEt3 Trace 
12 50c water 80°C NEt3 Decomposition 
13 50d xylene 160°C - No reaction 
14 50d cymene 200°C - No reaction 
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The product dimethyl 2,6-anthraquinonedicarboxylate 49 was isolated in 98% 
yield. It is critical to perform the reaction under inert gas atmosphere for excellent yields. 
Taking advantage of the low solubility of the anthraquinone 49, the purification process 
was simply achieved by reflux the crude in ethyl acetate followed by filtration. There was 
no significant drop in yield when the reaction was running on a 20-gram scale. 
 With the condition in hand, other hydroxybenzoquinones with substituted pyrones 
were tested. The results were listed in Scheme 1.31. Some of them showed good 
reactivities in a moderated yield. To obtain the best results, the reaction is better 
performed at a lower temperature (45°C) with a stoichiometric amount of triethylamine 
as the base. There was no extension of the reaction time needed. Reacting nitrile 
substituted pyrone with 50e also provided the product naphthoquinone 51b in 50% yield. 
It is worth to mention that the reaction between 3-propynylcoumalate with 50e afforded 
51c. Presumably because the corresponding intermediate alkyne was transformed into a 
methyl ketone through a hydration process.  
 
Scheme 1.31 Scope of the reaction to naphthoquinones 
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 When changing the hydroxyquinone to lawsone 52 as the substrate, the base 
promoted Diels-Alder reaction was carried under the same condition. The corresponding 
anthraquinones 53a and 53b were obtained in moderate yield when the reactants were 
methyl coumalate and 5-cyanopyrone (Scheme 1.32).  
 
 Scheme 1.32 Scope of the reaction to anthraquinones 
 Tomochaedin methyl ester, which was isolated from Oospora colorans, was 
previously synthesized by Thomson in a 10-step route. Our synthesis was started with the 
naphthoquinone 51a. Deprotection of methyl ether by AlCl3 afforded the intermediate 54. 
Methylation using paraformaldehyde with formic acid (generated in situ by oxidation of 
the paraformaldehyde) in a sealable tube to provide the tomochaedin methyl ester in 40% 
over 2 steps from 51a (Scheme 1.33).  
 
Scheme 1.33 Total synthesis of Tomochaedin methyl ester 
40 
 
1.3.      Conclusion 
In the first chapter, we have successfully developed new methods for the Diels-
Alder reaction of pyrones, and expanded the scope for this reaction.  
Acyclic enamines reacted readily with methyl coumalate at ambient temperature, 
forming the bicyclic lactone structure. The lactone was stable enough to be isolated, and 
it could be further transformed to meta-substituted isophthalic acids in a base catalyzed 
pathway. Further optimization provided a one-pot synthesis of isophthalates in a green 
pathway. When using the enamine of cyclohexanone, the intermediate lactone would 
extrude carbon dioxide in situ and afford the corresponding tetrahydronaphthalene in 
good yield. 
A scalable synthesis towards dimethyl 2,6-naphthalate was also developed. The 
reaction of methyl coumalate with the enamine of ethyl 4-oxocyclohexane-1-carboxylate 
afforded the tetrahydronaphthalene. Further dehydrogenation was achieved by 
bromination/elimination cascade. The final product dimethyl 2,6-naphthalate was 
obtained by recrystallization in methanol after the acid catalyzed transesterification. 
Methods for purification was also introduced without column chromatography, thus made 
this process capable of being scaled up. We had successfully performed this route in a 
kilogram scale, and the overall yield was about 30%. This method showed the potential 
application of sustainable pyrones in the polymer industry.  
The Diels-Alder reaction of the indole magnesium iodide salt with methyl 
coumalate formed the bicyclic lactone intermediate, which spontaneously undergoes ring 
opening process affording the dihydrocarbazole in good yield. Under the same condition, 
the reaction of methyl coumalate with 3-substituted indole also provided the lactone 
intermediate. Acid catalyzed ring opening reaction at -20°C gave the corresponding 
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hydrocabazoles in moderate yield. This Diels-Alder/ring opening cascade transformation 
introduced a quaternary center on the 3-position of indole, and provided an alternative 
synthetic pathway towards indole alkaloids.  
A base promoted Diels-Alder reaction of hydroxyquinones with electron poor 
pyrones was successfully developed. Methyl coumalate or 5-cyanopyrone reacted readily 
with 2,5-dihydroxybenzoquinone in acetonitrile with a catalytic amount of triethylamine, 
affording the anthraquinone in 98% yield at a 20-gram scale. The results of different 
pyrones reacted with hydroxyquinones and lawsone were promising, affording the 
corresponding naphthoquinone or anthraquinone in good yield. A total synthesis of 
tomichaedin methyl ester was also achieved in an overall yield is 40%. This method 
showed a way of synthesizing the monomer of polyethylene anthracenate (PEA) from a 




1.4.      Experimental 
General Information 
All starting materials were purchased from Sigma-Aldrich, AK Scientific 
Institution and Oakwood Chemical; Solvents were all purchased from Sigma-Aldrich and 
Fisher Scientific, and used without further distillation. All reactions were monitored by 
thin layer chromatography (TLC) and 1H NMR. All yields refer to separated yield after 
column chromatography unless indicated. Dibromomethane was used as external 
standard for calculating all NMR yields. TLC was obtained by silica plate using UV light 
as a visualizing agent or Potassium permanganate solution with heat. All columns were 
performed with silica gel 60Å, particle size 40-63 μm. 1H and 13C NMR spectra were 
acquired in CDCl3 or other deuterated solvents on a Varian MR-400 or Bruker Avance III 
600 MHz spectrometer. 
General Procedure and Selected Spectrum Data 
General procedure for Diels-Alder reaction between methyl coumalate with 
morpholine enamines. 
 
 (E)-4-(3-methylbut-1-en-1-yl)morpholine. To a 100 mL round bottom flask 
charged with 3-methylbutanal (4.30 g, 50 mmol, 1.1 equiv.) and 25 mL of toluene, 
morpholine (3.96 g, 45 mmol, 1.0 equiv.) was added. PTSA (100 mg, 0.58 mmol, 0.012 
equiv.) was then added to the previous solution as a solid. The flask was attached with a 
Dean-Stark water separator, and stirred under reflux for 2 hours, then cooled to R.T. 
Solvents were removed by distillation, and the crude was dissolved in DCM. The organic 
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solution was washed with water three times followed by brine, and dried over Na2SO4. 
The DCM was removed under vacuum and the crude product was used to the next step 
without further purification (6.9g, quantitative yield). The enamine could be stored at -
20°C for months. 1H NMR (400 MHz, Chloroform-d) δ = 5.78 (dd, J=14.0, 1.1, 1H), 4.44 
(dd, J=14.0, 7.1, 1H), 3.72 (dd, J=6.1, 3.6, 4H), 2.76 (dd, J=6.2, 3.7, 4H), 2.32 – 2.17 (m, 
1H), 0.98 (d, J=6.8, 6H).  
 
General procedure of synthesizing Diels-Alder lactone adducts. Methyl 7-
isopropyl-8-morpholino-3-oxo-2-oxabicyclo[2.2.2]oct-5-ene-6-carboxylate. To a 
solution of methyl coumalate (310 mg, 2.0 mmol, 1.0 equiv.) in 2 mL of DCM, enamine 
(310 mg, 2.0 mmol, 1.0 equiv.) was added dropwise. The mixture was stirred at room 
temperature for 2 hours. The solvent was removed, and the crude was purified by column 
chromatography (50% ethyl acetate: 50% hexane) to afford the product as a clear oil 
(608mg, 98%). 1H NMR (400 MHz, Chloroform-d) δ = 7.22 (ddd, J=6.2, 2.1, 0.8, 1H), 
5.60 (dd, J=2.2, 1.1, 1H), 3.83 – 3.78 (m, 4H), 3.62 (qdd, J=11.0, 6.1, 2.9, 3H), 2.95 – 
2.92 (m, 1H), 2.48 (dq, J=9.6, 3.0, 2H), 2.27 – 2.18 (m, 2H), 1.85 – 1.76 (m, 1H), 1.22 
(dd, J=8.9, 5.1, 1H), 1.09 (d, J=6.6, 3H), 1.04 (d, J=6.7, 3H); 13C NMR (101 MHz, 
Chloroform-d) δ = 171.73, 162.72, 137.93, 134.56, 75.20, 67.27, 65.38, 52.38, 51.08, 
46.67, 44.38, 30.45, 20.85, 20.83; HRMS (ESI-QTOF) calcd for C16H23NO5 [M + H]
+ 




3-isopropyl-5-(methoxycarbonyl)benzoic acid (10) and dimethyl 5-
isopropylisophthalate. To a solution of the lactone (15 mg, 0.05 mmol, 1.0 equiv.) in 0.2 
mL of methanol, K2CO3 (7 mg, 0.05 mmol, 1.0 equiv.) was added at R.T., The mixture 
was stirred overnight, and quenched with NH4Cl solution. After extraction with ethyl 
acetate, the organic phase was washed with brine and dried by Na2SO4. Column 
chromatography gave products in 89% combined yield.  
 
3-isopropyl-5-(methoxycarbonyl)benzoic acid; White powder. 1H NMR (400 
MHz, Chloroform-d) δ = 8.59 (t, J=1.6, 1H), 8.16 (d, J=1.6, 2H), 3.96 (s, 3H), 3.05 (hept, 
J=7.0, 1H), 1.32 (d, J=6.9, 6H); 13C NMR (101 MHz, Chloroform-d) δ = 170.87, 166.55, 
150.07, 133.08, 132.70, 130.92, 129.75, 129.16, 52.55, 34.13, 23.91. HRMS (ESI-QTOF) 
calcd for C12H14O4 [M - H]
- 221.0819, found 221.0819.  
 
Dimethyl 5-isopropylisophthalate; clear oil. 1H NMR (400 MHz, Chloroform-d) 
δ = 8.50 (d, J=1.6, 1H), 8.10 (t, J=1.6, 2H), 3.94 (s, 3H), 3.03 (hept, J=6.8, 1H), 1.29 (d, 
J=6.9, 6H); 13C NMR (101 MHz, Chloroform-d) δ = 166.71, 149.88, 132.22, 130.73, 
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3-ethyl-5-(methoxycarbonyl)benzoic acid; White powder. 1H NMR (400 MHz, 
Chloroform-d) δ = 8.59 (d, J=1.7, 1H), 8.14 (d, J=1.7, 2H), 3.96 (s, 3H), 2.78 (q, J=7.6, 
2H), 1.30 (t, J=7.7, 3H); 13C NMR (101 MHz, Chloroform-d) δ = 171.65, 166.55, 145.40, 
134.47, 134.04, 130.93, 129.85, 129.06, 52.58, 28.71, 15.51; HRMS (ESI-QTOF) calcd 
for C11H12O4 [M + H]
+ 209.0808, found 209.0807. 
 
General procedure for Diels-Alder/elimination between methyl coumalate 
and cyclic enamines. Ethyl 4-(pyrrolidin-1-yl)cyclohex-3-ene-1-carboxylate. To a 
solution of ethyl 4-oxocyclohexane-1-carboxylate (1.70 g, 10 mmol, 1.0 equiv.) in 15 mL 
of toluene, was added pyrrolidine (1.1 g, 15 mmol, 1.5 equiv.). The flask was attached 
with a Dean-Stark water separator and refluxed until completion (monitored by the crude 
1H NMR). The reaction was allowed to cool, and toluene was removed under vacuum. 
The crude enamine was taken to the next step without further purification. 
2-ethyl 7-methyl 1,2,3,4-tetrahydronaphthalene-2,7-dicarboxylate. A solution 
of methyl coumalate (644 mg, 4.2 mmol, 1.0 equiv.) in 10 mL of methanol was slowly 
added to a solution of enamine (1.22 g, 5.5 mmol, 1.3 equiv.) in 2 mL of methanol at 
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ambient temperature. The mixture was stirred for 2 hours and quenched with 1M HCl 
solution. The mixture was extracted with ethyl acetate 3 times and dried by Na2SO4. 
Purification by column chromatography afforded the product as light-yellow oil (760 mg, 
70% yield).  
 
Methyl (Z)-2-((E)-(2-oxocyclopentylidene)methyl)but-2-enoate. Colorless oil; 
1H NMR (400 MHz, Chloroform-d) δ = 7.08 (s, 1H), 7.03 (q, J=7.3, 1H), 3.75 (s, 3H), 
2.44 (td, J=7.1, 2.7, 2H), 2.37 (t, J=7.8, 2H), 1.99 – 1.90 (m, 2H), 1.82 (d, J=7.3, 3H); 13C 
NMR (101 MHz, Chloroform-d) δ = 207.28, 166.96, 143.12, 140.14, 130.08, 125.16, 
52.18, 38.35, 29.24, 20.13, 16.02; HRMS (ESI-QTOF) calcd for C11H14O3 [M + H]
+ 
195.1020, found 195.1016. 
 
2-ethyl 7-methyl 1,2,3,4-tetrahydronaphthalene-2,7-dicarboxylate. Light 
yellow powder; 1H NMR (400 MHz, Chloroform-d) δ = 7.79 (s, 1H), 7.76 (d, J=8.0, 1H), 
7.13 (d, J=7.9, 1H), 4.18 (q, J=7.1, 2H), 3.89 (s, 3H), 3.07 – 3.01 (m, 2H), 2.98 – 2.80 (m, 
2H), 2.78 – 2.69 (m, 1H), 2.26 – 2.13 (m, 1H), 1.95 – 1.80 (m, 1H), 1.28 (t, J=7.1, 3H); 
13C NMR (101 MHz, Chloroform-d) δ = 175.24, 167.33, 141.47, 135.37, 130.54, 129.07, 
127.88, 127.12, 60.76, 52.15, 39.89, 31.63, 28.82, 25.70, 14.41; HRMS (ESI-QTOF) 
calcd for C15H18O4 [M + H]




Methyl 5,6,7,8-tetrahydronaphthalene-2-carboxylate. Clear oil; 1H NMR (400 
MHz, Chloroform-d) δ = 7.77 – 7.68 (m, 2H), 7.11 (d, J=7.7, 1H), 3.89 (s, 3H), 2.80 (tt, 
J=4.2, 2.2, 4H), 1.81 (p, J=3.8, 4H); 13C NMR (101 MHz, Chloroform-d) δ = 167.57, 
142.97, 137.42, 130.56, 129.31, 127.42, 126.64, 52.08, 29.77, 29.44, 23.11, 23.01; 
HRMS (ESI-QTOF) calcd for C12H14O2 [M + H]
+ 191.1067, found 191.1067. 
 
General procedure for Diels-Alder reaction between methyl coumalate with 
phenylacetaldehyde enamines. 4'-methoxy-[1,1'-biphenyl]-3,5-dicarboxylic acid.  
Step 1: To a solution of 2-(4-methoxyphenyl)acetaldehyde(300 mg, 2.0 mmol, 
1.0 equiv.) in 10 mL of dry chloroform at R.T., 4Å molecular sieves (1 gram, activated at 
160°C for 48 hours) was added, followed by adding morpholine (348 mg, 4.0 mmol, 2.0 
equiv.) in one portion. The solution was stirred at R.T. for 3 hours (monitored by the 
crude 1H NMR) and filtered. After being concentrated, the solid was washed with dry 
hexane and decant to give the corresponding enamine as a white solid (420 mg, 96% 
yield), which was used directly for the next step. 1H NMR (400 MHz, Chloroform-d) δ = 
7.13 (d, J=8.4, 2H), 6.80 (d, J=8.2, 2H), 6.48 (d, J=14.2, 1H), 5.43 (d, J=14.2, 1H), 3.81 – 
3.74 (m, 7H), 3.04 – 2.96 (m, 4H). 
Step 2: The enamine from step 1 and methyl coumalate (246mg, 1.6 mmol, 0.8 
equiv.) was mixed in a 10 mL round bottom flask, and 6 mL of DCM was added at 
ambient temperature. The mixture was stirred for 90 minutes, and then the solvent was 
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removed under vacuum. The crude product was taken to the next step without further 
purification. 
Step 3: The crude from step 2 was treated with 2 mL of 2M KOH aqueous 
solution, and additional 2 mL of MeOH. The mixture was stirred under reflux for 8 hours. 
After the reaction was completed, the solution was cooled down to R.T., and acidified to 
pH = 1 by 1M HCl solution. The mixture was extracted by ethyl acetate three times, and 
the organic phase was washed with 1M NaOH solution 3 times. The aqueous phase was 
then acidified by 3M HCl (white precipitate was formed immediately) and extracted by 
ethyl acetate twice. The ethyl acetate was washed with water followed by brine, and was 
dried over Na2SO4. After removing solving under vacuum, the crude was washed by 
hexane/ether to afford the final product diacid as a white powder (80% yield over 3 steps). 
 
4'-methoxy-[1,1'-biphenyl]-3,5-dicarboxylic acid; White powder. 1H NMR (400 
MHz, DMSO-d6) δ = 13.22 (s, 2H), 8.41 (s, 1H), 8.32 (s, 2H), 7.68 (d, J=8.3, 2H), 7.06 
(d, J=8.3, 2H), 3.81 (s, 3H); 13C NMR (101 MHz, DMSO-d6) δ = 166.64, 159.55, 140.76, 
132.06, 130.73, 130.71, 128.12, 114.67, 55.26; HRMS (ESI-QTOF) calcd for C15H12O5 




[1,1'-biphenyl]-3,5-dicarboxylic acid; White powder. 1H NMR (400 MHz, 
DMSO-d6) δ = 13.25 (s, 2H), 8.47 (s, 1H), 8.37 (s, 2H), 7.73 (d, J=7.6, 2H), 7.51 (t, 
J=7.5, 2H), 7.43 (t, J=7.2, 1H); 13C NMR (101 MHz, DMSO-d6) δ = 166.54, 141.14, 
138.45, 132.12, 131.33, 129.27, 128.84, 128.36, 126.96; HRMS (ESI-QTOF) calcd for 
C14H10O4 [M - H]
- 241.0506, found 241.0508. 
 
2'-methyl-[1,1'-biphenyl]-3,5-dicarboxylic acid; White powder. 1H NMR (400 
MHz, DMSO-d6) δ = 13.25 (s, 2H), 8.48 (s, 1H), 8.07 (s, 2H), 7.37 – 7.23 (m, 4H), 2.22 
(s, 3H); 13C NMR (101 MHz, DMSO-d6) δ = 166.51, 141.98, 139.40, 134.70, 133.63, 
133.60, 131.47, 130.59, 129.50, 128.55, 128.14, 126.28, 19.99, 19.95; HRMS (ESI-
QTOF) calcd for C15H12O4 [M - H]
- 255.0663, found 255.0666. 
 
3'-bromo-[1,1'-biphenyl]-3,5-dicarboxylic acid; White powder. 1H NMR (400 
MHz, DMSO-d6) δ = 13.35 (s, 2H), 8.47 (s, 1H), 8.35 (s, 2H), 7.92 (s, 1H), 7.74 (d, 
J=8.0, 1H), 7.63 (d, J=8.3, 1H), 7.46 (t, J=7.9, 1H); 13C NMR (101 MHz, DMSO-d6) δ = 
166.39, 140.86, 139.57, 132.17, 131.53, 131.28, 131.26, 131.10, 129.62, 129.55, 129.34, 
126.18, 122.57; HRMS (ESI-QTOF) calcd for C14H19BrO4 [M - H]





2-ethyl 7-methyl naphthalene-2,7-dicarboxylate. To a solution of 
tetrahydronaphthalene (105 g, 0.4 mol, 1.0 equiv.) in 1.2 L of chloroform at room 
temperature under argon, NBS (146 g, 0.82 mol, 2.05 equiv.) and AIBN (660 mg, 4 
mmol, 1.0 %) was added, and argon was sparging through the mixture for 20 minutes. 
The solution was allowed to stirred under reflux for 8 hours. After cooling down to R.T., 
triethylamine (230 mL, excess) was added, and was stirred for additional 2 hours. 1.5 M 
HCl solution was added to neutralize the amine. The mixture was extracted by DCM then 
dried over Na2SO4. The crude oil was recrystallized from hexane twice to afford the 
product as a light-yellow crystal (96 grams, 93% yield). 1H NMR (400 MHz, 
Chloroform-d) δ = 8.69 (s, 2H), 8.16 (ddd, J=8.6, 5.2, 1.6, 2H), 7.90 (d, J=8.6, 2H), 4.45 
(q, J=7.1, 2H), 3.99 (s, 3H), 1.45 (t, J=7.1, 3H); 13C NMR (101 MHz, Chloroform-d) δ = 
166.94, 166.44, 137.56, 132.43, 132.32, 131.80, 128.75, 128.36, 128.19, 128.14, 127.75, 




3-(Methoxycarbonyl)-4a,9a-dihydro-9H-carbazole-1-carboxylic acid. Under 
argon atmosphere, indole (176 mg, 1.5 mmol, 1.5 equiv.) was dissolved in 3 mL of dry 
toluene and 3.5 mL of dry diethyl ether at 0 °C, methylmagnesium iodide solution (3.0 M 
in diethyl ether, 0.43 mL, 1.3 equiv.) was added dropwise. The reaction mixture was 
stirred at 0 °C for 15 minutes to fully deprotonate, and then a suspension of methyl 
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coumalate (154 mg, 1.0 mmol, 1.0 equiv.) in 1.0 mL of dry toluene was added in one 
portion. Then the mixture was sonicated until a yellow suspension formed (about 1 
minute). After additional 5 minutes stirring at room temperature, the reaction was 
quenched by adding saturated ammonia chloride solution, and was extracted with ethyl 
acetate three times, and was dried over Na2SO4. Recrystallization from DCM/hexane 
gave the product as a yellow crystal (203 mg, 75% yield). mp 163-165 °C; 1H NMR (400 
MHz, DMSO-d6) δ = 12.31 (s, 1H), 11.93 (s, 1H), 7.83 (s, 1H), 7.77 (d, J 7.8, 1H), 7.61 
(d, J 2.8, 1H), 7.48 (d, J 8.0, 1H), 7.22 (t, J 7.3, 1H), 7.16 (t, J 7.3, 1H), 6.90 (d, J 11.6, 
1H), 6.04 (d, J 11.5, 1H), 3.65 (s, 3H); 13C NMR (101 MHz, DMSO-d6) δ = 167.15, 
167.08, 137.97, 135.96, 131.54, 129.46, 127.01, 123.53, 123.00, 122.64, 120.62, 118.20, 





(epoxymethano)carbazole-3-carboxylate. Using the same procedure for the reaction of 
methyl coumalate with indole. This reaction was preformed in a scale of 3-methylindole 
(787 mg, 6.0 mmol, 1.2 equiv.), methyl coumalate (771 mg, 5.0 mmol, 1.0 equiv.) and 
methylmagnesium iodide solution (3.0 M in diethyl ether, 1.83 mL, 1.1 equiv.). The final 
product was recrystallized from ethyl acetate/hexane at -20 °C as a light yellow crystal 
(950 mg, 67% yield), which can be stored at -20 °C for weeks (decomposed to starting 
materials at room temperature). 1H NMR (400 MHz, DMSO-d6) δ = 12.44 (s, 1H), 8.13 
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(s, 1H), 7.71 (d, J 8.1, 1H), 7.58 (d, J 7.7, 1H), 7.45 (d, J 1.5, 1H), 7.32 (t, J 7.4, 1H), 7.25 
(t, J 7.6, 1H), 6.94 (dd, J 11.5, 1.6, 1H), 6.13 (d, J 11.5, 1H), 3.68 (s, 3H), 2.27 (s, 3H); 
13C NMR (101 MHz, DMSO-d6) δ = 166.69, 166.53, 136.77, 135.71, 132.29, 129.30, 
125.06, 123.75, 123.68, 122.19, 119.23, 117.16, 111.42, 110.57, 51.70, 9.43; HRMS 
(ESI-QTOF) calcd for C16H15NO4 [M + H]
+ 286.1074, found 286.1073. 
 
3-(Methoxycarbonyl)-4a-methyl-4a,9a-dihydro-9H-carbazole-1-carboxylic 
acid. The starting material lactone (110 mg, 0.34 mmol) was dissolved in dry THF at 
ambient temperature. To it, 3 drops of trifluoromethanesulfonic acid were added, and the 
solution was stored at -20 °C for 7 days. After the reaction was completed, the mixture 
was dissolved in ethyl acetate, and washed three times with water, then with brine. The 
organic phase was dried over Na2SO4. Recrystallization from DCM/hexane gave the 
product as a yellow solid (32 mg, 29% yield). mp 179-180 °C; 1H NMR (600 MHz, 
DMSO-d6) δ = 12.46 (s, 1H), 8.38 (s, 1H), 7.71 (d, J 8.2, 1H), 7.64 (dt, J 7.7, 0.9, 1H), 
7.55 (dt, J 15.8, 1.0, 1H), 7.41 (d, J 1.4, 1H), 7.37 (td, J 7.1, 1.3, 1H), 7.31 (td, J 7.5, 0.9, 
1H), 6.52 (d, J 15.7, 1H), 3.83 (s, 3H), 2.32 (d, J 1.2, 3H); 13C NMR (151 MHz, DMSO-
d6) δ = 167.65, 166.09, 137.14, 136.94, 135.36, 129.65, 124.32, 124.11, 123.12, 122.69, 
119.42, 118.36, 111.04, 110.27, 52.07, 9.50; HRMS (ESI-QTOF) calcd for C16H15NO4 





The product was synthesized according to the previous procedure. Yellow crystal (31% 
yield) after recrystallization in DCM/hexane. mp 73-75 °C; 1H NMR (400 MHz, 
Acetone-d6) δ = 8.44 (s, 1H), 7.74 (dd, J 15.8, 0.8, 1H), 7.70 – 7.62 (m, 2H), 7.43 (s, 1H), 
7.37 (td, J 7.1, 1.2, 1H), 7.29 (td, J 7.1, 1.0, 1H), 6.69 (d, J 15.9, 1H), 6.06 (ddt, J 16.7, 
10.0, 6.5, 1H), 5.21 (dq, J 17.1, 1.7, 1H), 5.09 (ddt, J 10.0, 2.0, 1.4, 1H), 3.86 (s, 3H), 
3.55 (dt, J 6.5, 1.4, 2H); 13C NMR (101 MHz, Acetone-d6) δ = 166.94, 138.67, 137.88, 
136.86, 136.84, 136.76, 130.10, 125.22, 125.05, 123.68, 123.67, 123.55, 122.29, 120.65, 




General Procedure for Diels-Alder reaction of methyl coumalate with 
hydroxyquinone.  
 
Synthesis of 9a as an example. Methyl 6-methoxy-5,8-dioxo-5,8-
dihydronaphthalene-2-carboxylate. To a solution of methyl coumalate (555 mg, 3.6 
mmol, 0.9 equiv.) and hyxroxyquinone (552 mg, 4.0 mmol, 1.0 equiv.) in 20 mL of 
acetonitrile, triethylamine (405 mg, 4.0 mmol, 1.0 equiv.) was added, and the solution 
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turned into dark red color immediately. The mixture was stirred under argon at 45°C for 
24 hours (monitored by 1H NMR) then was cooled to ambient temperature. 0.5M HCl 
solution was added, and the mixture was extracted by ethyl acetate three times. The 
organic phase was washed with brine and was dried over Na2SO4. Purification by column 
chromatography gave the product as a light brown solid (45% yield). 
 
2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione.  
Step 1. To a suspension of dihydroxyquinone (6.0 g, 43 mmol, 1.0 equiv.) in 80 
mL of dry methanol, BF3·Et2O (14.9 g, 105 mmol, 2.5 equiv.) was added. The suspension 
was refluxed under argon for 2 hours, then cooled in an ice bath. The solid cake was 
collected by filtration, and was washed by cold methanol. The crude product was 
dissolved in DCM, washed with water then brine, and was dried over Na2SO4. Solvent 
was removed under vacuo, and hexane was added. The solid 2,5-dimethoxycyclohexa-
2,5-diene-1,4-dione was collected by filtration. 
Step 2. To a suspension of 2,5-dimethoxycyclohexa-2,5-diene-1,4-dione (3.36 g, 
20 mmol, 1.0 equiv.) in 80 mL of THF and 80 mL of methanol at room temperature, a 
solution of KOH (1.68 g, 30 mmol, 1.5 equiv.) in 80 mL of water was added slowly. 
After 50 minutes stirring, 1M HCl was added to the purple solution. The mixture was 
extracted by DCM twice, and was dried over Na2SO4. The product hydroxyquinone was 




Methyl 7-hydroxy-5,8-dioxo-5,8-dihydronaphthalene-2-carboxylate. Under 
argon, a suspension of methoxy quinone (180 mg, 0.73 mmol, 1.0 equiv.) and AlCl3 (195 
mg, 1.46 mmol, 2.0 equiv.) in 5 mL of DCE was stirred under reflux for 1 hour. The 
reaction mixture was allowed to cool, 0.5M HCl was added. Extraction with ethyl acetate 
three times, and the organic phase was dried over Na2SO4. Filtration through a thin silica 
pad followed by removal of solvent afforded the product as a solid, which was pure 
enough to go to the next step. 
 
Tomichaedin methyl ester. To a stainless-steel reactor, hydroxy quinone (68 mg, 
0.3 mmol, 1.0 equiv.) was dissolved in 2 mL of ethanol/water (1:1 ratio) mixture, and 
paraformaldehyde (40 mg, 1.2 mmol, 4.0 equiv.) was added. The reactor was sealed 
under air, and was heated to 200°C for 3 hours.  After cooling, the mixture was diluted by 
0.5 M HCl, and extracted with ethyl acetate. Filtration through a thin silica pad (the 
compound is found to be unstable on silica) afforded the Tomichaedin methyl ester as a 
light yellow solid (40% over two steps). 
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Dimethyl 9,10-dioxo-9,10-dihydroanthracene-2,6-dicarboxylate. 1H NMR (400 
MHz, DMSO-d6) δ 8.70 (d, J = 1.7 Hz, 2H), 8.45 (dd, J = 8.0, 1.8 Hz, 2H), 8.38 (d, J = 
8.1 Hz, 2H). 3.97 (s, 6H). The 13C NMR was not able to obtain due to the low solubility 
of compound. HRMS (ESI-QTOF) calcd for C18H12O6 [M + e]
- 324.0634, found 
324.0653. 
   
2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione. The NMR matches to the 
literature reported. 1H NMR (400 MHz, Chloroform-d) δ 7.33 (s, 1H), 6.04 (s, 1H), 5.93 
(s, 1H), 3.89 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 182.91, 181.88, 161.61, 
155.58, 105.80, 103.05, 57.15. HRMS (ESI-QTOF) calcd for C7H6O4 [M - H]
- 153.0193, 
found 153.0190.  
   
Methyl 7-methoxy-5,8-dioxo-5,8-dihydronaphthalene-2-carboxylate. 1H NMR 
(400 MHz, Chloroform-d) δ 8.75 (d, J = 1.6 Hz, 1H), 8.39 (dd, J = 8.0, 1.5 Hz, 1H), 8.16 
(d, J = 8.1 Hz, 1H), 6.23 (s, 1H), 3.98 (s, 3H), 3.93 (s, 3H). 13C NMR (101 MHz, 
Chloroform-d) δ 184.19, 179.48, 165.55, 160.94, 135.16, 134.89, 134.84, 131.30, 128.23, 






7-methoxy-5,8-dioxo-5,8-dihydronaphthalene-2-carbonitrile. 1H NMR (400 
MHz, Chloroform-d) δ 8.42 (d, J = 1.6 Hz, 1H), 8.21 (d, J = 8.0 Hz, 1H), 8.02 (dd, J = 8.0, 
1.6 Hz, 1H), 6.28 (s, 1H), 3.95 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 183.17, 
178.47, 160.79, 137.33, 134.46, 131.64, 130.74, 127.32, 117.44, 117.20, 110.62, 56.96. 
  
Methyl 4-acetyl-7-methoxy-5,8-dioxo-5,8-dihydronaphthalene-2-carboxylate. 
1H NMR (400 MHz, Chloroform-d) δ 8.80 (d, J = 1.6 Hz, 1H), 8.13 (d, J = 1.6 Hz, 1H), 
6.22 (s, 1H), 3.99 (s, 3H), 3.94 (s, 3H), 2.54 (s, 3H). 13C NMR (101 MHz, Chloroform-d) 
δ 203.35, 184.04, 178.64, 164.73, 160.86, 143.85, 134.97, 131.86, 131.67, 131.56, 128.73, 
110.27, 56.99, 53.18, 30.93. HRMS (ESI-QTOF) calcd for C15H12O6 [M + H]
+ 289.0707, 
found 289.0706. 
   
Methyl 9,10-dioxo-9,10-dihydroanthracene-2-carboxylate. 1H NMR (400 MHz, 
Chloroform-d) δ 8.94 (dd, J = 1.7, 0.6 Hz, 1H), 8.43 (dd, J = 8.1, 1.7 Hz, 1H), 8.39 (dd, J 
= 8.1, 0.6 Hz, 1H), 8.34 (dddd, J = 6.8, 5.1, 3.4, 0.6 Hz, 2H), 7.88 – 7.80 (m, 2H), 4.01 (s, 
3H). 13C NMR (101 MHz, Chloroform-d) δ 182.69, 182.41, 165.67, 136.23, 135.29, 
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134.71, 134.66, 134.58, 133.70, 133.59, 133.53, 128.80, 127.74, 127.63, 127.57, 52.96. 
HRMS (ESI-QTOF) calcd for C16H10O4 [M + H]
+ 267.0652, found 267.0651. 
   
9,10-dioxo-9,10-dihydroanthracene-2-carbonitrile. 1H NMR (400 MHz, 
Chloroform-d) δ 8.60 (d, J = 1.7 Hz, 1H), 8.43 (d, J = 8.0 Hz, 1H), 8.34 (dt, J = 5.5, 2.8 
Hz, 2H), 8.05 (d, J = 8.2 Hz, 1H), 7.87 (dd, J = 5.5, 3.3 Hz, 2H). 13C NMR (101 MHz, 
Chloroform-d) δ 181.91, 181.43, 136.85, 135.87, 135.08, 135.06, 134.06, 133.33, 133.21, 
131.53, 128.26, 127.84, 127.83, 117.98, 117.41. 
   
Methyl 7-hydroxy-5,8-dioxo-5,8-dihydronaphthalene-2-carboxylate. 1H NMR 
(400 MHz, Chloroform-d) δ 8.75 (d, J = 1.7 Hz, 1H), 8.44 (dd, J = 8.0, 1.7 Hz, 1H), 8.20 
(d, J = 8.0 Hz, 1H), 7.39 (s, 1H), 6.43 (s, 1H), 4.00 (s, 3H). 13C NMR (101 MHz, 
Chloroform-d) δ 184.29, 181.44, 165.39, 156.85, 136.07, 135.74, 134.71, 129.71, 128.01, 
127.29, 111.35, 53.07. HRMS (ESI-QTOF) calcd for C12H8O5 [M]
- 232.0370, found 
232.0323. 
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Tomichaedin methyl ester. 1H NMR (400 MHz, Chloroform-d) δ 8.71 (d, J = 1.7 
Hz, 1H), 8.39 (dd, J = 8.0, 1.8 Hz, 1H), 8.20 (d, J = 8.0 Hz, 1H), 3.99 (s, 3H), 2.13 (s, 
3H). 13C NMR (101 MHz, cdcl3) δ 184.46, 180.62, 165.51, 153.74, 135.77, 135.66, 
134.47, 129.71, 127.63, 127.28, 121.45, 53.00, 8.98. HRMS (ESI-QTOF) calcd for 
C13H9O5 [M - H]
- 245.0455, found 245.0456. 
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CHAPTER 2.    SYNTHETIC APPLICATION OF NITROQUINONES 
2.1.      Chapter 2. Introduction  
2.1.1. Quinone Subunits in Natural Product 
Quinones are a class of organic molecules that are derived from aromatic phenols 
by oxidation. Ortho-hydroquinone and para-hydroquinone can be oxidized, giving 1,2-
benzoquinone and 1,4-benzoquinone. As shown in Figure 2.1, other examples including 
1,4-naphthoquinone or 9,10-anthraquinones are also in the quinone family. 
 
Figure 2.1 Structure of quinones, naphthoquinone and anthraquinone 
 Quinone subunits are commonly isolated from plants and animals. Some quinones 
are recognized as biological or pharmacologically active compounds, such as vitamin K 
or the Q coenzyme. These compounds play important roles in metabolism, mostly 
functioning as electron carriers. Other quinones have excellent bioactivities. Some 




Figure 2.2 Bioactive quinone containing structures 
Tosolini tested a series of substituted 1,4-naphthoquinones in 1970 and showed 
their antibacterial and antifungal properties2. Rifamycin was discovered in 1957 from the 
metabolites of N. mediterranei3. It was found to have the inhibition ability of DNA-
dependent RNA polymerase in 19694. Two decades later, a mechanism study by Werel 
indicated that rifamycin binds to the bacterial DNA and RNA. The corresponding binding 
complex was destabilized, and RNA synthesis was thus aborted5. Nowadays, the 
synthetic derivative rifampicin (also known as rifampin) it is used to treat several types of 
bacterial infections6. A similar analogue of rifampicin, named rifabutin, is an antibiotic 
used to treat tuberculosis and other infections7. It is especially useful for those patients 
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who are tolerating HIV disease. Mitomycin is a drug that is used as a chemotherapeutic 
agent against tumor. It is mostly used in the treatment of anal cancers and breast cancers. 
The mechanism of action is that mitomycin forms a complex with DNA which induces 
cell-cycle arrest and apoptosis8. Mitomycin is also used in strabismus surgery to reduce 
adhesions and fibrosis9. Other clinical applications such as eliminating bacteria, where 
mitomycin is functioning as a DNA crosslinker10.  
Studies showed that aziridinyl benzoquinones have good antitumor activities. 
Therefore, a number of aziridinyl benzoquinones were synthesized including diaziquone 
and triaziquone. These quinones were used to treat meningeal leukemia and malignant 
astrocytomas in phase I and phase II clinical investigations11. The activity of diaziquone 
against a variety types of leukemias was exclusively studied, and over 30% of the 
patients responded to the treatment12. However, due to the toxicity, the aziridinyl 
benzoquinones are no longer used as chemotherapeutic agents for cancers. 
The biosynthesis of quinones is achieved in an enzyme catalyzed pathway from 
natural building blocks. For example, the biosynthesis of vitamin K was revealed by 
Bentley in 1982.13 As shown in Scheme 2.1, Shikimate was firstly converted to chorismic 
acid via a bio-catalytic dehydration process. 2-Ketoglutarate was added to the chorismic 
acid, followed by losing pyruvate and carbon dioxide gave the benzenoid derivative o-
succinylbenzoate (OSB). Cyclization of OSB afforded the naphthalenoid compound 1,4-
dihydroxy-2-naphthoate (DHNA) as an important intermediate. The installation of the 
farnesyl unit was accomplished by prenyl transferase enzyme, and the trans-farnesyl 
pyrophosphate was effectively converted to demethylmenaquinone (DMK) after 
oxidation. The methylase catalyzed methylation reaction facilitated the formation of 
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menaquinone, as known as vitamin K2. This transformation is happening in cells very 
effectively. 
 Scheme 2.1 Biosynthesis of Vitamin K2 
Nitrogen substituted quinones, for example, amino quinones and nitro quinones, 
are considered to be very important compounds in nature. A great number of nitrogen 
containing quinones/hydroquinones showed good activities against different diseases 
(Figure 2.3). 1-(2,5-dimethoxy-4-nitrophenyl)-2-amino-propane (DON), discovered by 
Huidobro-Toro, is shown to have an affinity for the 5-HT receptor in rat brain 
membranes. Extensive research proved that it also acts directly on brain neurotransmitter 
receptors, and they might be prototypes for the future development of novel selective 
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drugs14. GL-331, a derivative of nitro substituted podophyllotoxin, was shown good 
activities against tumor and virus. It was considered to be a potential chemotherapeutic 
agent targeting HIV disease15. Pin 1 was patented by Pintex Pharmaceuticals Inc. in 
200416. This nitrohydroquinone structure was a potential anti-cancer drug used for skin 
cancers. It was a photochemotherapeutic agent when activated by light. Pin 1 showed 
specificity targeting cancer cells, and the therapeutic ratio is greater than 50, which was 
an improvement when comparing to the current non-specific photochemotherapeutic 
drugs. 
 Figure 2.3 Drug candidates with nitroquinone subunit 
2.1.2. Current Synthesis of Nitroquinone Containing Compounds 
Considering the biological and pharmaceutical importance of the nitro containing 
aromatics, methods were developed towards the synthesis of nitroquinones. The most 
straight forward way is by direct nitration reaction. As shown in Scheme 2.2, in 1981, 
Ortlieb reported a double nitration reaction using concentrated nitric acid with propanoic 
acid to nitrate the macrocyclic hydroquinone17. Three years later, a direct nitration 
reaction of naphthaquinone was reported by Cardin18. The condition they used was 
treating naphthoquinone with concentrated sulfuric acid and nitric acid, and the 
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corresponding nitration product was isolated after recrystallization. An improved method 
of synthesizing nitronaphthoquinone was introduced by Ma in 201319, where they used 
nitronium tetrafluoroborate as a mild nitration reagent. 
 
 Scheme 2.2 Synthesis of nitroquinone by direct nitration 
The direct nitration was extensively used for the synthesis of nitroquinone 
compounds. For example, Morigi reported a general synthesis of the potential antitumor 
agents - the thiazolo[2’,3’:2,3]imidazo[4,5-c]quinoline heterocyclic system, where they 
used the substituted 1,4-dimethoxybenzene 1 as the starting material20. Early stage 
nitration by nitric acid gave the nitrobenzene 2 as a mixture. Further functionalization of 
2 afforded the heterocyclic compound 3. However, one significant drawback of this 
synthesis was the lack of regioselectivity of the nitration reaction, losing more than half 
of the material in the reduction/cyclization step. Once tetracyclic compound 4a was 
isolated, oxidative demethylation of 4a and imine formation gave the final target 6 in two 
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steps. Biological results indicated that the tetracyclic quinone 5 showed appreciable 
activity on leukemia (Scheme 2.3). 
 
 Scheme 2.3 Synthesis of antitumor agents 5 and 6 via nitration reaction 
 Because not all substrates could tolerate the strong acidic and oxidative 
environment in nitric acid, an alternative route towards nitroquinones was developed. The 
nitro group can be installed at the early stage on the aromatic ring, and the following 
oxidation reaction will afford the corresponding nitroquinone. In 2010, Chen showed an 
oxidative pathway to nitrohydroquinone, where they used para-hydroxybenzaldehyde 7 
as the precursor. mCPBA oxidation gave the nitroquinone intermediate 8, and eventually 
led to the total synthesis of (+)-haplophytine21. Harmata developed a method using 4-
methoxyaniline as the precursor. Under the treatment of ceric ammonium nitrate, the 
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nitroquinone was obtained in 11% yield22. Similarly, Wang used bis(α-methyl-4-
nitrobenzyl) peroxide (BMNP) as the oxidant and cobalt-porphyrins complex as the 
catalyst.  Alkylnitroquinone was oxidized affording the nitroquinone in about 50% yield23. 
The high temperature of the condition and the expensive catalyst limited the extension of 
this methodology. In 2018, da Silva Júnior published an approach towards several 
naphthaquinone compounds via diphenyl diselenide oxidation24. After screening 
conditions, they found the hydrogen peroxide can be used as a co-oxidant, and the 
reaction needed to be run under oxygen atmosphere. Therefore, the corresponding 
naphthoquinones can be synthesized in moderate yield with a lower catalyst loading 
(20%). Unfortunately, nitro substituted 1-naphthalenol did not show good reactivity and 
the yield was only 30% (Scheme 2.4). 
 
Scheme 2.4 Synthesis of nitroquinones by oxidation 
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 Other approaches towards nitroquinones such as nucleophilic substitution strategy 
were also reported. In 2008, Shreeve published a synthesis of sodium nitranilate 10 using 
chloranil 9 as the starting material25.  Compound 9 was treated in hot aqueous sodium 
nitrite solution, and the sodium nitranilate was obtained as a crystal. This material was 
used to make highly dense nitrogen rich salts, which was viewed as a potential energetic 
material for the storage of a large amount of chemical energies (Scheme 2.5). 
 
 Scheme 2.5 Synthesis of nitroquinone by nucleophilic substitution 
2.1.3. Synthesis of Benzoquinone and its Reactions 
The most straightforward synthesis of benzoquinones is by the oxidation of 
hydroquinones. Varieties of common oxidants are able to catalyze this transformation, 
and selected methods were abbreviated in Scheme 2.6. 
In 1983, Valderrama reported a method using manganese dioxide26. Most of the 
hydroquinones were successfully oxidized to the corresponding benzoquinones in 
moderate yield. However, in this report, they found that the highly reactive quinones 
were not suitable for this preparation method. When changing the oxidant to manganese 
dioxide (impregnated with nitric acid), the reaction of those reactive quinones went 
smoothly. Finch introduced a direct synthesis of benzoquinones from hydroquinones 
using polymer-supported (diacetoxyiodo)benzene as a “clean” oxidant27. The products 
were obtained with high yield and high purity. The work up process could be simply 
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achieved by filtration of the resin. Another direct synthesis of quinones was reported by 
Kobayashi in 2008, where they took the polymer-incarcerated platinum as the catalyst28. 
Oxygen was used as the co-oxidant in this reaction with about 1% of the catalyst loading, 
and benzoquinones were synthesized in moderate yield. More importantly, they claimed 
that the platinum catalyst can be recovered and reused at least 13 times. Further recycling 
of the catalyst could result in a lower yield with a gradual decline of the catalytic activity. 
A powerful oxidative demethylation strategy towards substituted benzoquinones was 
reported by Bryant in 200629. They used silica gel-supported ceric ammonium nitrate 
(CAN) as the oxidant. Instead of using hydroquinones, 1,4-Dimethoxybenzenes can be 
directly converted to benzoquinones effectively in  
 Scheme 2.6 Selected oxidants for 1,4-hydroquinone oxidation 
dichloromethane in excellent yield. Unfortunately, when applying this method to the 
oxidation of 2-nitro-1,4-dimethoxybenzene, there was no nitroquinone isolated. 
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 Silver (I) oxide was the mostly used oxidant for benzoquinone synthesis. 
Hydroxyquinones bearing different functional groups were easily oxidized affording the 
corresponding benzoquinones. If an electron withdrawing group was attached on the 2-
position of the benzoquinone, a nucleophile could add to the 3-position of the aromatic 
ring through a Michael addition mechanism (Scheme 2.7). Tautomerization of the 
cyclohexanedione intermediate afforded the substituted hydroquinone as the product.  
 
 Scheme 2.7 Synthesis of kalafungin analogue via addition to naphthoquinone 12 
 In 2004, Ray reported a short synthesis of kalafungin analogue 15 from a simple 
2-acetyl-1,4-dihyroxylnaphthalene 1130. Oxidation of 11 by silver (I) oxide afforded the 
electron poor naphthoquinone 12, which underwent a nucleophilic addition reaction with 
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an electron rich furan. A cascade intramolecular Michael addition reaction of the 
intermediate 13 gave the tetracyclic compound 14 in one pot. The final step was ceric 
ammonium nitrate oxidation, and the naphthoquinone was regenerated, resulting in an 
intramolecular ketal formation. Kalafungin analogue 15 was obtained in a 3-step 
synthesis.  
 
 Scheme 2.8 Enaminone one-pot nucleophilic addition to benzoquinone 
 Another example of nucleophilic addition to nitroquinone was reported by 
Valderrama in 200631. Their synthesis started with 2-acetyl-1,4-dihydroxyquinone 16. It 
was oxidized by manganese dioxide to afford the benzoquinone 17. Nucleophilic addition 
to 17 with 3-aminocyclohexen-1-one gave the intermediate 18, which tautomerized to 
hydroquinone, and immediately cyclized to the tricyclic compound 19. Further oxidation 
of 19 by silver (I) oxide afforded the quinone 20. The author also indicated that this 
process can be done in one pot, by treating 16 and the aminocyclohexen-1-one with 
excess amount of silver (I) oxide in dichloromethane (Scheme 2.8).  
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 Respecting the usefulness of quinones in total synthesis, transformations of acetyl 
naphthoquinone 12 were exclusively studied (Scheme 2.9). Varieties of nucleophiles 
were tested under different conditions32. In 1978, Kraus reported that 2-alkoxyfurans 
could be used as a butenolide anion equivalent, which would lead to the formation of the 
Michael addition adduct 21. The 9-deoxykalafungin was efficiently synthesized in 5 steps 
via this strategy. A few years later, Giles reported an oxidative allylation reaction of the  
 
Scheme 2.9 Types of nucleophiles that added to naphthaquinone 12 
naphthoquinone 12. Vinylacetic acid was used in the presence of silver (I) nitrate and 
potassium peroxodisulphate, and the allylation product 22 was obtained in 43% yield. 
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However, in this report, they claimed that a small quantity of an isomeric side product 
was formed, and the structure was assigned as a tricyclic naphthalene. Uno published 
another nucleophilic addition reaction that alkylated the 3-position of the naphthoquinone 
12 in 1986. They took allyltrimethylstannane reagent as the nucleophile, and treated 
together with 12 together at a low temperate. The presence of Lewis acid was critical for 
this transformation to be successful.  BF3·OEt2 was found to be the best catalyst. The 
alkylated naphthoquinones were obtained from moderate to high yields. A 1,3-diketone 
can also be used as the nucleophile with the naphthoquinone 12. For example, a report by 
Chuang in 2004 showed that the ester 24 can be synthesized from 12 and ethyl 
nitroacetate in basic conditions. With DBU as the base, the yield could reach up to 66% 
after 16 hours. Similarly, Kimpe published a ytterbium triflate catalyzed conjugate 
addition to 1,4-naphthoquinones in 2009. According to Kimpe’s results, Lewis acid 
catalyst was essential to promote this transformation, otherwise, a complex mixture 
would be obtained. After screening conditions, they found using 5% ytterbium triflate 
together with cyclic β-ketoesters as the nucleophile, the tetracyclic quinone 25 could be 
obtained in over 80% yield.  
2.1.4. Previous Synthesis of Phenantroviridone and Lagumycin 
Phenantroviridone and Lagumycin B are natural products isolated from marine-
derived Micromonospora sp. in 2015 (Figure 2.4)33. Studies showed that they have 
excellent in vitro cytotoxicity against OVCAR4 and Kuramochi cancer cell lines. 
Lagumycin B is an angucycline antibiotic but its structure remains uncharacterized till 
2015. It showed enhanced cytotoxicity when treated with murine cell lines MOSE, with 
LC50 values of 9.80 μM. Phenantroviridone was first discovered in the late 1980s from 
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Streptomyces sp., and it was reported to have antibiotic properties34. Further studies on 
the biological activities of these natural products are still ongoing. 
 
Figure 2.4 Bio-active natural products isolated from Micromonospora sp. 
Recognizing the excellent bio-activities of Phenantroviridone and Lagumycin B, 
synthetic approaches were reported by various researchers.  
The first total synthesis of Phenantroviridone was accomplished by Gould in 1990 
shown in Scheme 2.1035. His approach started with 2,5-dimethylphenol. Bromination and 
Knoevenagel condensation gave the cinnamate analogue 26 in 7 steps. The key step in 
their synthesis was the formation of the quinone ring, where they used a Hauser-Kraus 
annulation reaction in this transformation. The lithium anion of 27 was generated by 
LDA, and the cyclization product 28 was obtained in 68% yield. This compound was 
reductively methylated in acetone, and converted to the amide 29 in four steps. Lithiation 
of 29 by tert-butyllithium, and the metalation intermediate was quenched by DMF 
affording an aldehyde. The aldehyde intermediated was obtained in 40% yield, along 
with a non-separable impurity. Hoffmann rearrangement of the aldehyde mixture under 
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basic bromine solution gave the carbamate 30. The hydrolysis and cyclization steps were 
performed in hot basic solution, and the final product phenantroviridone was synthesized 
after the deprotection and oxidation. 
 
 Scheme 2.10 The first total synthesis of phenantroviridone 
Other approaches towards phenantroviridone were also reported (Scheme 2.11)36. 
In 1997, Snieckus published a synthesis route where he took the commercially available 
benzyl alcohol 31, and converted to oxaborole 32 by ortho-directed metalation protocol. 
Suzuki-Miyaura cross coupling reaction with 33 gave the tricyclic framework. Further 
functionalization afforded the phenantroviridone in 6% overall yield. Another cross 
coupling approach was introduced by Echavarren in 2001. They used an organotin 
reagent. The benzylic acid 38 was transformed into the aromatic stannane 39 in 7 steps.  
Stille coupling of the organotin 39 with the naphthoquinone 33 afforded a tricyclic 
intermediate, which was eventually converted to phenantroviridone in 4 steps. 
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In 1999, Valderrama used another route to construct the tetracyclic system37. The 
highlight of the synthesis is the formation of the pyridine ring. They reacted the 
dimethylhydrazone 35 with bromonaphthoquinone 36, and stirred in acetonitrile at room 
temperature for 5 days. The cyclization reaction occurred slowly and the Diels-Alder 
adduct 37 was obtained in 86% yield with excellent regioselectivity. Aromatization of 37 
in the presence of hydrochloric acid and oxidation of the cyclohexene ring, yielded the 
phenantroviridone skeleton in 14% yield overall. 
 Scheme 2.11 Previous synthesis towards phenantroviridone analogues 
A recent synthesis of phenantroviridone skeleton was reported by Kita in 201138. 
They developed a new coupling method for the synthesis of biaryl naphthoquinones using 
the hypervalent iodine reagent - CF3 substituted phenyliodine bis-(trifluoroacetate) 
(PFIFA). The oxidative coupling reaction would happen when treating the electron rich 
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aromatic with naphthoquinone, with the single-electron-transfer oxidizer (PFIFA) 
together with BF3·Et2O. The coupling product 42 was synthesized in 80% yield from the 
benzyl acetate 40 and 1,4-dimethoxynaphthalene 41. Amination of 42 followed by 
intramolecular cyclization reaction afforded the phenantroviridone skeleton in 40% 
overall yield. However, they indicated the attempts to control the regioselectivity for the 
oxidative coupling reaction failed. Installation of the hydroxyl group on the 
naphthoquinone ring requires further investigation. 
 
 Scheme 2.12 Previous synthesis towards Lagumycin skeleton 
Scheme 2.12 shows the attempts towards Lagumycin skeleton39. In 1997, Moore 
reported a strategy using photoannulation reaction as the key step. The synthesis started 
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with a commercially available material diisopropyl squarate 43. Additions to the 
cyclobutenone 43, followed by thermolysis gave the naphthoquinone 46. Photoannulation 
under light and DDQ afforded the Lagumycin skeleton in 13% overall yield, together 
with a regioisomer as a 1:1 mixture. Another attempt was published by Koning in 2016. 
They took 2-bromonaphthalene 47 and the boronic acid 48, and Suzuki-Miyaura coupling 
reaction gave the biaryl product 49 in moderate yield. After the reduction of the aldehyde, 
the only isolated cyclization product was the lactone 50. Other attempts to form the 
Lagumycin skeleton were not successful. 
2.2.      Results and Discussion  
New methods for the synthesis of nitrogen containing quinones are needed. Our 
plan was to use nitrobenzoquinone as a building block and to explore reactions to 
functionalize this molecule. In Scheme 2.13, the naphthoquinone core structure of 
rifamycin can be abbreviated as shown below. Our plan was to develop new methods to 
introduce a G group on the 3-position, as well as a regioselective reaction to construct the 
aromatic ring on the 5 and 6-position of the quinone ring. We decided to use the 
nucleophilic 1,4-addition reaction and the Diels-Alder reaction as our synthetic strategies. 
 
 Scheme 2.13 Functionalization of the core structure of rifamycin 
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 In order to achieve our target, the nucleophilic addition mechanism was proposed 
in Scheme 2.14. The nitroquinone was generated from the oxidation of 2,5-
dihydroxynitrobenzene 51. Nucleophilic Michael addition reaction followed by the 
tautomerization afforded the substituted hydroquinone structure, which could be further 
oxidized by the excess amount of oxidant, resulting in the stable 3-substituted 
nitrobenzoquinone.  
 
Scheme 2.14 Proposed mechanism of nucleophilic addition to nitroquinone 
Our approach began with the synthesis of the nitrobenzoquinone precursor 2,5-
dihydroxynitrobenzene 51. A mild nitration reagent “claycop” (clay-supported copper 
nitrate) was used to nitrate 1,4- dimethoxybenzene, followed by demethylation under 
hydrobromic acid. The product 51 was obtained in 79% yield over 2 steps. (Scheme 2.15) 
 
 Scheme 2.15 Synthesis of 2,5-dimethoxynitrobenzene 51 
 Oxidation of 51 was first tested by silver (I) oxide. The corresponding product 
nitrobenzoquinone 52 was found hard to isolate, and unstable to storage in the room 
temperature. The evidence of the existence for the quinone 52 was proved by the addition 
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of 2,3-dimethylbutadiene to the reaction mixture, and the corresponding Diels-Alder 
adduct 53 was isolated in 68% yield. (Scheme 2.16) 
 
 Scheme 2.16 In situ Diels-Alder reaction of nitrobenzoquinone 52 
 With the previous results in hand, our synthesis of 3-substituted 
nitrobenzoquinone 54 started with electron rich indoles. We tested a number of oxidants, 
including manganese dioxide and iron (III) chloride, and the best result was obtained  
 
 Scheme 2.17 Adducts substituted at C-3 of indole 
when using 2.0 equivalent of silver (I) oxide as the oxidant in DCE. The corresponding 
indolequinones 54 were obtained in high yield. 
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As shown in Scheme 2.17, an indole without C-3 substituent reacted readily with 
nitrobenzoquinone. A methyl group on the 2-position did not inhibit the reaction (54i).  
Electron donating substituents on indoles gave generally good yields, however, electron 
withdrawing effect of the nitro group on the indole ring (54e) lowered the yield. 
Although a variety of substituents can be presented on indole ring, the reaction did not  
Table 2.1 Screening for Lewis Acids and Solvents (3-methylindole) 
 
Entry Lewis Acid Solvent Result 
1 - CHCl3 0% 
2 Bi(NO3)3 DCM Trace 
3 CeCl3 DCM 35% 
4 Cu(OAc)2 DCM 0% 
5 Bi(NO3)3 MeOH 0% 
6 CeCl3 CHCl3 0% 
7 CeCl3 DCE 49% 
8 - DCE 28% 
9 CeCl3 THF <5% 
10 CeCl3 Acetone 0%
a 
11 CeCl3 DMSO 0% 
a No reaction observed 
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occur with the phenol (54h). The reaction did not require additional workup, and the 
purification process was by loading the crude mixture to column chromatography. 
3-Substituted indoles were known to have lower nucleophilicity, and the addition 
reaction did not occur when treating 3-methylindole with 2,5-dihydroxynitrobenzene 51 
under the same conditions. We then tested several Lewis acids to catalyze this 
transformation, and the results were listed in Table 2.1. Unfortunately, bismuth (III) 
nitrate and copper acetate did not afford any promising results. Solvents screening 
showed that the adduct 55a can be formed in low yield in dichloroethane. Our best result 
was obtained when using 2.0 equivalent of silver (I) oxide and 1.0 equivalent of cerium 
(III) chloride as the catalyst.  The desired product 55a can be obtained in 49% yield after 
three hours at ambient temperature. It was believed that the cerium (III) chloride 
promoted the conjugate addition to quinones. 
 
 Scheme 2.18 Adducts of 51 with 3-substituted indoles 
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 With the conditions in hand, we evaluated the scope of the addition reactions of 3-
substituted indoles to nitrobenzoquinones. As shown in Scheme 2.18, methyl or alkyl 
substitution on the indole nitrogen did not hinder the reaction (entry 55b, 55c and 55d). 
An electron withdrawing group on the C-3 position caused the inhibition of the reactivity 
(55e and 55i). However, the electron inductive effect was lowered when a carbonyl group 
was at two carbon units away from the indole ring and led to the formation of the desired 
adduct 55d. 
 
 Scheme 2.19 Tandem conjugate addition/Diels-Alder reaction 
Additionally, a more complex structure can me generated if a diene is connected 
to the indole nitrogen atom (Scheme 2.19). The diene 56 was synthesized from 3-
methylindole and 1-bromo-2,4-hexadiene. The reaction between 51 and 56 under the 
Lewis acid catalyzed condition afforded the adduct 58. This transformation was believed 
88 
 
to be a tandem Michael addition and tautomerization to form the intermediate 57, 
followed by an intramolecular Diels-Alder reaction cascade to give the final adduct 58.  
The cis relationship of H1 and H2 was assigned by the 1D NOE experiment. 
In addition to indoles, other electron rich aromatics, including heteroaromatic 
were tested. Table 2.2 listed the solvent and oxidant screening for the nucleophilic 
addition reaction to the in situ generated nitrobenzoquinone. Among all the conditions 
evaluated, two equivalents of silver (I) oxide in dichloroethane was found to be the most 
effective. Other common oxidants such as iron (III) chloride and manganese (IV) dioxide 
did not afford satisfactory results. The reaction can be carried at the ambient temperature 
under air, but it was critical to perform the reaction in the absence of light.  
 Table 2.2 Optimization of the reaction 
 
Entry Product Oxidant (200%) Solvent Yield 
1 5a FeCl3 CHCl3 No Product 
2 5a FeCl3 DMF <5% 
3 5a MnO2 CHCl3 No Product 
4 5a MnO2 DMF <5% 
5 5a Ag2O CHCl3 51% 
6 5a Ag2O DCE 70% 
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7 5f MnO2 CHCl3 No Product 
8 5f MnO2 Acetone No Product 
9 5f MnO2 Et2O No Product 
10 5f MnO2 EtOAc No Product 
11 5f MnO2 DMF No Product 
12 5f Ag2O CHCl3 95% 
13 5f Ag2O DCE 97% 
A wide range of aromatics and heterocycles were tested under the same 
conditions. As illustrated in Scheme 2.20, the electron rich benzenes showed good 
reactivities to nitrobenzoquinone, forming the addition products in good yield (5a - 5d). 
The 1,2,3,5-tetrasubstituted benzene did not give any products, possibly because of the 
steric hinderance. Other heterocycles such as 2-alkylfuran (59e, 59f), thiophene (59g), 
pyrrole (59h, 59i) and aniline derivatives (59j - 59l) afforded the corresponding adducts 
in moderated yield. It is worth mentioning that the tetrahydroquinolines (59k) reacted 
readily with nitrobenzoquinone in a stereospecific manner, presumably due to the 





 Scheme 2.20 Scope of the reaction 
Surprisingly, the reaction between nitrobenzoquinone with phosphorus ylides 
gave the benzofuran derivatives (59m - 59o) in moderate yield. The proposed mechanism 
was given in Scheme 2.21. The conjugate addition of ylides to nitrobenzoquinone gave 
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the intermediate 60, where an intramolecular cyclization reaction happened forming the 
ketal 61. Elimination of triphenylphosphine oxide would give the benzofuran structure. 
This result affords an alternative route towards nitro substituted benzofuran structures. 
 
Scheme 2.21 Synthesis of benzofuran using phosphorus ylides 
With the understanding of the addition reaction to nitrobenzoquinone, we 
implemented a total synthesis towards phenanthroviridin and Lagumycin skeleton 
(Scheme 2.22). The synthesis began with the nitrohydroquinone 51, and the addition 
reaction with the TBS protected benzyl alcohol 62 afforded the adduct 63 as a 4:1 
mixture of regioisomers. Luckily, the major isomer was the desired product (63a).  
The mixture was then treated with trimethylsiloxy-1,3-butadiene, and the Diels-
Alder adduct 64 was formed with excellent regioselectivity. The double bond not bearing 




Scheme 2.22 Total synthesis of phenanthroviridin and Lagumycin skeleton 
in mild acidic condition afforded the alcohol 65, which was not stable at room 
temperature and immediately taken onto the oxidative aromatization step by PCC. The 
naphthoquinone 66 was isolated in 76% yield over 3 steps. Reduction of the nitro group 
by palladium on carbon under hydrogen atmosphere afforded the amino hydroquinone 
intermediate, which was oxidized by MnO2 yield the amino quinone 67. An acid 
catalyzed deprotection/intramolecular cyclization reaction led to the lagumycin analogue 
68. Alternatively, using TBAF to deprotect the TBS group, followed by oxidation of the 
benzylic alcohol and an intramolecular imine formation afforded the phenathroviridone 
skeleton 69. The structure was confirmed by x-ray crystallography. 
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2.3.      Conclusion 
In conclusion, we have successfully developed a method to synthesize 
nitrobenzoquinone derivatives via an in situ oxidation – conjugate addition – re-oxidation 
strategy. Silver (I) oxide in dichloroethane was the best conditions, and the desired 
products were obtained in moderate yield. Several nucleophiles showed good reactivity, 
including indoles, electron rich benzenes and heterocycles. When using CeCl3 as the 
catalyst, indoles with 3-alkyl substitution could also react with nitrobenzoquinone. 
Substituted benzofurans can also be generated under the same conditions when reacting 
with phosphorus ylides.  A divergent synthesis of the lagumycin and phenathroviridone 
skeletons is reported. This route is flexible and scalable, and it will permit the future 




2.4.      Experimental 
 
“Claycop” is the clay-supported copper nitrate. 
Step 1: 2-nitrobenzene-1,4-diol. To a solution of 1,4-dimethoxybenzene (1.65 g, 
12 mmol, 1.0 equiv) in 70 mL of acetic anhydride and 35 mL of diethyl ether, “claycop” 
(2.1 mmol/g, 7.2 g, 1.2 equiv) was added as a solid in a single portion. The suspension 
was stirred at room temperature for 3 hours and the reaction was monitored by TLC. 
After the reaction was finished, the mixture was filtered through a thin silica pad, and 
washed with diethyl ether 3 times. The solvent was removed under vacuum to give the 
crude product 1,4-dimethoxy-2-nitrobenzene that can be used for the next step without 
further purification. 
Step 2: The crude 1,4-dimethoxy-2-nitrobenzene was mixed with 30 mL of HBr 
(48% solution in water) in a 50 ml round bottom flask, and heated to reflux for 3 hours. 
The reaction mixture was cooled to room temperature, and diluted with ethyl acetate. The 
organic phase was washed by water then saturated NaHCO3 solution, and was dried over 
Na2SO4. Flask column chromatography gave the product as a yellow solid (79% over 2 




General Procedure: nucleophilic addition of 3-alkyl indoles to nitroquinone. 
To a 5 ml round bottom flask charged with solid nitrohydroquinone (47 mg, 0.3 mmol, 
1.0 equiv), Ag2O (139 mg, 0.6 mmol, 2.0 equiv) and CeCl3 anhydrous (74 mg, 0.3 mmol, 
1.0 equiv), dichloroethane 3 ml was added followed by fast addition of 3-methylindole 
(43 mg, 0.33 mmol, 1.1 equiv). The reaction flask was covered with aluminum foil and 
stirred at room temperature for 3 hours, and filtered through a silica pad. Solvent was 
removed under vacuum and the crude was loaded on column. Purification by flash 
column chromatography (ethyl acetate: hexane 1:2) gave the pure product as a brown 
solid (42 mg, 49% yield).  
 
2-(3-methyl-1H-indol-2-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. 1H NMR 
(400 MHz, Acetone-d6) δ = 10.12 (s, 1H), 7.61 (d, J=8.0, 1H), 7.47 (d, J=8.2, 1H), 7.25 
(ddd, J=8.2, 6.9, 1.1, 1H), 7.16 – 7.06 (m, 3H), 2.26 (s, 3H). 13C NMR (101 MHz, 
Acetone-d6) δ = 185.99, 178.19, 139.32, 138.28, 135.90, 130.21, 129.40, 125.49, 122.02, 
120.71, 120.60, 118.84, 112.73, 10.30; HRMS (ESI-QTOF) calcd for C15H10N2O4 [M + 
H]+ 283.0713, found 283.0707. 
 
2-(1-allyl-3-methyl-1H-indol-2-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. Dark 
brown solid; 1H NMR (600 MHz, Acetone-d6) δ = 7.59 (d, J=7.9, 1H), 7.43 (d, J=8.3, 
1H), 7.26 (ddd, J=8.3, 7.0, 1.1, 1H), 7.18 (q, J=1.2, 2H), 7.12 (t, J=7.5, 1H), 5.86 (ddd, 
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J=16.2, 11.0, 5.8, 1H), 5.17 (dd, J=17.2, 1.8, 1H), 5.13 (dd, J=10.3, 1.6, 1H), 4.82 (ddt, 
J=16.6, 5.6, 1.7, 1H), 4.60 (ddt, J=16.6, 6.1, 1.6, 1H), 2.22 (s, 3H); 13C NMR (151 MHz, 
Acetone-d6) δ = 185.90, 178.31, 152.57, 139.15, 138.38, 136.21, 134.77, 129.83, 129.20, 
124.51, 123.67, 120.58, 120.48, 117.99, 116.10, 111.47, 48.45, 29.84, 9.57; HRMS (ESI-
QTOF) calcd for C18H14N2O4 [M + H]
+ 323.1018, found 323.1026. 
 
2-(1,3-dimethyl-1H-indol-2-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. Black 
Solid; 1H NMR (600 MHz, Acetone-d6) δ = 7.57 (d, J=8.0, 1H), 7.43 (d, J=8.3, 1H), 7.28 
(t, J=7.3, 1H), 7.20 (s, 2H), 7.11 (d, J=7.3, 1H), 3.65 (s, 3H), 2.21 (s, 3H); 13C NMR (151 
MHz, Acetone-d6) δ = 186.04, 178.35, 152.70, 139.72, 138.41, 136.27, 129.78, 128.87, 
124.60, 124.43, 120.43, 120.41, 115.65, 110.58, 31.77, 9.62; HRMS (ESI-QTOF) calcd 
for C16H12N2O4 [M + H]
+ 297.0870, found 297.0866. 
 
3-(2-(2-nitro-3,6-dioxocyclohexa-1,4-dien-1-yl)-1H-indol-3-yl)propanal. Dark 
brown solid; 1H NMR (600 MHz, Acetone-d6) δ = 10.15 (s, 1H), 9.72 (s, 1H), 7.68 (d, 
J=8.1, 1H), 7.46 (d, J=8.2, 1H), 7.26 – 7.22 (m, 1H), 7.20 (d, J=10.3, 1H), 7.16 (d, J=10.3, 
1H), 7.11 (t, J=7.5, 1H), 3.00 (t, J=7.4, 2H), 2.81 (t, J=7.4, 2H); 13C NMR (151 MHz, 
Acetone-d6) δ = 202.18, 185.59, 178.30, 139.15, 138.55, 136.17, 135.82, 130.49, 128.26, 
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125.08, 121.59, 120.88, 120.76, 120.49, 112.86, 44.80, 17.92; HRMS (ESI-QTOF) calcd 
for C17H12N2O5 [M + H]
+ 325.0810, found 325.0819. 
 
 3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-methyl-1H-indole. Dark Solid; 1H 
NMR (400 MHz, Acetone-d6) δ = 10.16 (s, 1H), 7.69 (d, J=8.1, 1H), 7.46 (d, J=8.3, 1H), 
7.23 (t, J=7.6, 1H), 7.20 (d, J=10.5, 1H), 7.16 (d, J=10.5, 1H), 7.10 (t, J=7.0, 1H), 3.82 (t, 
J=7.2, 2H), 2.94 (t, J=7.2, 3H), 0.89 – 0.81 (m, 9H), 0.00 (d, J=0.7, 6H); 13C NMR (101 
MHz, Acetone-d6) δ = 185.46, 178.06, 150.46, 138.95, 138.30, 135.81, 130.24, 128.82, 
124.92, 121.88, 120.85, 120.54, 119.09, 112.63, 64.15, 29.49, 26.26, 18.81, -5.22; HRMS 
(ESI-QTOF) calcd for C22H26N2O5Si [M + H]
+ 427.1684, found 427.1690. 
 
2-(3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-1-methyl-1H-indol-2-yl)-3-
nitrocyclohexa-2,5-diene-1,4-dione. Dark Solid; 1H NMR (400 MHz, Chloroform-d) δ 
= 7.64 (dt, J=8.1, 1.0, 1H), 7.36 – 7.30 (m, 2H), 7.17 (ddd, J=8.0, 5.1, 2.9, 1H), 6.99 (d, 
J=1.2, 2H), 3.81 (ddd, J=10.0, 8.4, 5.9, 1H), 3.68 (ddd, J=10.0, 8.2, 7.2, 1H), 3.54 (s, 3H), 
2.99 – 2.82 (m, 2H), 0.88 (s, 9H), 0.01 (d, J=2.2, 6H); 13C NMR (101 MHz, Chloroform-
d) δ = 184.59, 176.71, 150.91, 139.07, 137.28, 135.28, 129.08, 127.61, 124.28, 123.05, 
120.41, 120.16, 117.21, 109.95, 63.68, 31.54, 29.18, 26.18, 18.63, -5.10, -5.17; HRMS 
(ESI-QTOF) calcd for C23H28N2O5Si [M + H]





1,4-dione. Dark Solid; 1H NMR (400 MHz, Acetone-d6) δ = 7.69 (d, J=8.0, 1H), 7.47 (d, 
J=8.4, 1H), 7.30 (ddd, J=8.3, 7.0, 1.2, 1H), 7.21 (s, 2H), 7.13 (ddd, J=8.0, 7.0, 1.0, 1H), 
4.60 (d, J=12.4, 1H), 4.52 (d, J=12.4, 1H), 3.69 (s, 3H), 3.16 (s, 3H); 13C NMR (101 
MHz, Acetone-d6) δ = 184.72, 177.37, 138.56, 137.40, 135.51, 135.48, 128.80, 127.00, 
123.59, 120.05, 120.00, 115.62, 109.90, 65.05, 56.68, 30.73; HRMS (ESI-QTOF) calcd 
for C17H14N2O5 [M + H]
- 326.0908, found 326.0902. 
 
General Procedure: nucleophilic addition of 3-H indoles to nitroquinone. 
To a 4 ml glass vial, nitrohydroquinone (15.6 mg, 0.1 mmol) and Ag2O (46.4 mg, 
0.2 mmol) was mixed as a suspension in DCE (0.5 mL) at room temperature. Indole (14 
mg, 0.12 mmol) was added fast as a solid, and then the reaction mixture was vigorously 
stirred overnight without light.  After the reaction is finished (monitored by TLC), the 
mixture was filtered through a short silica pad, and flushed by ethyl acetate 3 times. The 
solution was concentrated under vacuum and dry loaded on a silica column. The crude 
product was purified by flash column chromatography (ethyl acetate: hexane 1:2) to 




2-(1H-indol-3-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. 1H NMR (400 MHz, 
Acetone-d6) δ = 11.24 (s, 1H), 7.72 (s, 1H), 7.54 (dt, J=8.1, 1.0, 1H), 7.46 (dt, J=8.1, 1.0, 
1H), 7.23 (ddd, J=8.2, 7.1, 1.2, 1H), 7.17 – 7.10 (m, 2H), 7.06 (d, J=10.2, 1H); 13C NMR 
(101 MHz, Acetone-d6) δ = 186.50, 178.51, 138.54, 137.85, 135.72, 132.68, 132.32, 
127.02, 124.08, 122.06, 121.37, 113.27, 105.01; HRMS (ESI-QTOF) calcd for 
C14H8N2O4 [M + H]
+ 269.0054, found 269.0057. 
 
2-(4-methoxy-1H-indol-3-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. Dark green 
solid; 1H NMR (600 MHz, Acetone-d6) δ = 11.00 (s, 1H), 7.45 (s, 1H), 7.19 – 7.14 (m, 
2H), 7.12 (d, J=8.2, 1H), 7.07 (d, J=10.2, 1H), 6.62 (d, J=7.6, 1H), 3.78 (s, 3H); 13C NMR 
(151 MHz, Acetone-d6) δ = 185.96, 178.42, 154.09, 148.27, 139.13, 138.27, 135.68, 
134.77, 127.81, 125.07, 118.24, 106.26, 103.58, 102.30, 55.62; HRMS (ESI-QTOF) 
calcd for C15H10N2O5 [M + H]




2-(7-methyl-1H-indol-3-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. Blue solid; 
1H NMR (600 MHz, Acetone-d6) δ = 11.24 (s, 1H), 7.67 (d, J=2.6, 1H), 7.28 (dd, J=5.9, 
3.3, 1H), 7.13 (d, J=10.2, 1H), 7.04 (dd, J=6.8, 3.6, 3H), 2.53 (s, 3H); 13C NMR (151 
MHz, Acetone-d6) δ = 186.42, 178.40, 138.40, 137.16, 135.66, 132.69, 131.82, 126.69, 
124.63, 122.62, 122.58, 122.23, 118.89, 105.41, 16.79; HRMS (ESI-QTOF) calcd for 
C15H10N2O4 [M + H]
+ 283.0713, found 283.0707. 
 
2-(5-methyl-1H-indol-3-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. Dark blue 
solid; 1H NMR (600 MHz, Acetone-d6) δ = 11.13 (s, 1H), 7.66 (s, 1H), 7.41 (d, J=8.3, 
1H), 7.24 (dt, J=1.8, 0.9, 1H), 7.12 (d, J=10.2, 1H), 7.07 (dd, J=8.2, 1.6, 1H), 7.05 – 7.02 
(m, 1H), 2.38 (s, 3H); 13C NMR (151 MHz, Acetone) δ = 186.47, 178.37, 147.32, 138.36, 
136.12, 135.65, 132.76, 132.37, 131.25, 127.24, 125.63, 121.00, 112.91, 104.65, 21.70; 
HRMS (ESI-QTOF) calcd for C15H10N2O4 [M + H]
+ 283.0713, found 283.0707. 
 
2-nitro-3-(5-nitro-1H-indol-3-yl)cyclohexa-2,5-diene-1,4-dione. Purple solid; 
1H NMR (600 MHz, Acetone-d6) δ = 11.70 (s, 1H), 8.57 (d, J=2.2, 1H), 8.17 (dd, J=9.0, 
2.2, 1H), 7.91 (s, 1H), 7.77 (d, J=9.0, 1H), 7.25 (d, J=10.2, 1H), 7.15 (d, J=10.2, 1H); 13C 
NMR (151 MHz, Acetone-d6) δ = 185.98, 178.69, 149.04, 143.57, 140.72, 138.87, 
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135.43, 133.75, 131.32, 126.64, 118.97, 118.71, 113.71, 106.61; HRMS (ESI-QTOF) 
calcd for C14H7N3O6 [M - H]
- 312.0262, found 312.0254. 
 
2-(4-methyl-1H-indol-3-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. Dark blue 
solid; 1H NMR (600 MHz, Acetone-d6) δ = 10.92 (s, 1H), 7.49 (d, J=2.6, 1H), 7.36 (d, 
J=8.2, 1H), 7.21 – 7.10 (m, 3H), 6.91 (d, J=7.3, 1H), 2.29 (s, 3H); 13C NMR (151 MHz, 
Acetone-d6) δ = 187.78, 178.46, 138.00, 137.96, 136.09, 134.64, 130.71, 128.41, 127.13, 
123.91, 123.10, 110.91, 103.88, 90.83, 20.92; HRMS (ESI-QTOF) calcd for C15H10N2O4 
[M - H]- 281.0568, found 281.0560. 
 
2-(1-methyl-1H-indol-3-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. Dark purple 
solid; 1H NMR (600 MHz, Acetone-d6) δ = 7.66 – 7.62 (s, 1H), 7.52 (d, J=8.2, 1H), 7.43 
(d, J=7.9, 1H), 7.30 (t, J=7.6, 1H), 7.17 (t, J=7.9, 1H), 7.13 (d, J=10.3, 1H), 7.05 (d, 
J=10.1, 1H), 3.97 (s, 3H); 13C NMR (151 MHz, Acetone-d6) δ = 187.82, 178.47, 150.39, 
138.00, 136.09, 134.66, 130.76, 128.46, 127.16, 123.97, 123.95, 123.17, 110.96, 103.92, 
20.99; HRMS (ESI-QTOF) calcd for C15H10N2O4 [M + H]




2-(2-methyl-1H-indol-3-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. Blue solid; 
1H NMR (600 MHz, Acetone-d6) δ = 10.81 (s, 1H), 7.36 (d, J=8.1, 1H), 7.31 (d, J=8.0, 
1H), 7.17 – 7.07 (m, 3H), 7.02 (ddt, J=8.4, 7.3, 1.3, 1H), 2.37 (s, 3H); 13C NMR (151 
MHz, Acetone-d6) δ = 186.19, 178.65, 150.93, 139.72, 138.56, 137.04, 135.82, 134.04, 
128.45, 122.85, 121.15, 119.80, 111.95, 101.93, 13.32; HRMS (ESI-QTOF) calcd for 
C15H10N2O4 [M - H]
- 281.0568, found 281.0565. 
Procedure for Tandem conjugate addition/Diels-Alder reaction.  
 
1-((2E,4E)-hexa-2,4-dien-1-yl)-3-methyl-1H-indole. Under argon atmosphere, 
NaH (60% suspension in oil, 320 mg, 8.0 mmol, 1.5 equiv) was added to 25 mL of dry 
DMF in a Schlenk flask, and the mixture was cooled to 0°C. A 10 mL of DMF solution 
of 3-methylindole (700 mg, 5.3 mmol, 1.0 equiv) was added to the previous suspension 
mixture dropwise, and the resulted solution was allowed to stirred at 0°C for 20 minutes. 
A solution of (2E,4E)-1-bromohexa-2,4-diene (1.28 g, 8 mmol, 1.5 euqiv) in 5 mL of dry 
DMF was added dropwise and the mixture was stirred at room temperature for additional 
20 minutes. The reaction was quenched with brine, and extracted by diethyl ether twice. 
The combined organic phase was washed by water followed by brine, and dried over 
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Na2SO4. The solvent was removed under reduced pressure, and the crude product was 
purified by column chromatography (ethyl acetate: hexane 1:6) gave compound as light 
red oil (810 mg, 73% yield). 1H NMR (400 MHz, Chloroform-d) δ = 7.56 (d, J=8.4, 1H), 
7.28 (d, J=8.4, 1H), 7.19 (t, J=7.5, 1H), 7.10 (t, J=7.2, 1H), 6.86 (s, 1H), 6.15 – 5.96 (m, 
2H), 5.73 – 5.62 (m, 2H), 4.67 (d, J=6.0, 2H), 2.32 (dt, J=1.9, 1.1, 3H), 1.73 (d, J=6.8, 
2H); 13C NMR (101 MHz, Chloroform-d) δ = 136.53, 132.82, 130.60, 130.48, 129.05, 
125.98, 125.50, 121.59, 119.15, 118.79, 110.65, 109.56, 47.97, 18.31, 9.82; HRMS (ESI-
QTOF) calcd for C15H17N [M + H]
+ 212.1434, found 212.1438. 
 
5,14-dimethyl-4a-nitro-4a,5,7a,8-tetrahydrobenzo[7,7a]isoindolo[2,1-
a]indole-1,4-dione. It was synthesized according to the general procedure of nucleophilic 
addition of 3-alkyl indoles to nitroquinone (0.3 mmol scale). After purification by flash 
column chromatography (ethyl acetate: hexane 1:3), the pentacyclic compound was 
obtained as a red crystal (46mg, 43% yield). 1H NMR (400 MHz, Chloroform-d) δ = 7.55 
(d, J=8.4, 1H), 7.21 (dd, J=7.9, 1.6, 2H), 7.09 (t, J=7.1, 1H), 7.02 (d, J=10.5, 1H), 6.79 (d, 
J=10.4, 1H), 6.21 (d, J=10.7, 1H), 5.63 (dt, J=9.4, 3.3, 1H), 4.43 (t, J=10.3, 8.7, 1H), 4.28 
(t, J=8.5, 1H), 4.08 – 3.98 (m, 1H), 3.30 (t, J=8.7, 1H), 2.20 (s, 3H), 1.14 (d, J=7.8, 3H); 
13C NMR (101 MHz, Chloroform-d) δ = 189.84, 185.53, 143.10, 138.52, 134.19, 132.14, 
130.93, 129.30, 124.78, 123.07, 119.60, 119.45, 109.47, 108.55, 99.16, 63.77, 45.00, 
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44.98, 37.15, 20.92, 10.39; HRMS (ESI-QTOF) calcd for C21H18N2O4 [M + H]
+ 
363.1339, found 363.1340. 
 
General Procedure for electron rich aromatics addition to nitroquinone. 
2',4'-dimethoxy-6-nitro-[1,1'-biphenyl]-2,5-dione. To a 5 ml round bottom flask, 
2-nitrobenzene-1,4-diol (47 mg, 0.3 mmol, 1.0 equiv.) and silver (I) oxide (139 mg, 0.6 
mmol, 2.0 equiv.) in dry DCE, 1,3-dimethoxybenzene (62 mg, 0.45 mmol, 1.5 equiv.) 
was added. The reaction mixture was allowed to stirred at ambient temperature without 
light (the flask was fully covered by aluminum foil) overnight. After the reaction is 
finished (tracked by TLC), the crude mixture was loaded directly on a silica column 
chromatography. Using ethyl acetate/hexane (1:3) as eluent affording the desired product 
as a highly colored solid (61 mg, 70% yield). 1H NMR (400 MHz, Chloroform-d) δ 7.06 
(d, J = 8.5 Hz, 1H), 6.99 (d, J = 10.2 Hz, 1H), 6.92 (d, J = 10.3 Hz, 1H), 6.54 (d, J = 8.5 
Hz, 1H), 6.49 (s, 1H), 3.84 (s, 3H), 3.73 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 
184.64, 177.43, 163.98, 158.84, 137.54, 135.20, 134.82, 131.31, 109.12, 105.53, 99.27, 
55.83, 55.76. HRMS (ESI-QTOF) calcd for C14H12NO6 [M + H]





General Procedure for phosphoric ylide addition to nitroquinone. 
4-nitrobenzofuran-5-ol. To a mixture of 2-nitrobenzene-1,4-diol (31mg, 0.2 
mmol, 1.0 equiv.) and silver (I) oxide (51 mg, 0.22 mmol, 1.1 equiv.) in dry DCE, 2-
(triphenyl-l5-phosphaneylidene)acetaldehyde (91 mg, 0.3 mmol, 1.5 equiv.) was added. 
The suspension was sonicated for a short time allowing forming a better mixture, and was 
stirred without light overnight (covered by aluminum foil). The mixture was diluted with 
DCM, and filtered through a silica pad. Solvents were removed under vacuo and the 
crude material was loaded on a silica column chromatography. Elute with ethyl 
acetate/hexane (1:3) afforded the product as a yellow solid (23 mg with recovering 10 mg 
of 4, 96% yield). 1H NMR (400 MHz, Chloroform-d) δ 11.14 (s, 1H), 7.80 (d, J = 2.1 Hz, 
1H), 7.73 (dd, J = 9.0, 0.9 Hz, 1H), 7.46 (dd, J = 2.1, 0.9 Hz, 1H), 7.06 (d, J = 9.0 Hz, 
1H). 13C NMR (101 MHz, Chloroform-d) δ 154.25, 149.21, 149.05, 123.37, 121.52, 
115.80, 108.17. HRMS (ESI-QTOF) calcd for C8H5NO4 [M]
- 178.0146, found 178.0148. 
  
2',4',6'-trimethoxy-6-nitro-[1,1'-biphenyl]-2,5-dione. 1H NMR (400 MHz, 
Acetone-d6) δ 7.14 (d, J = 10.3 Hz, 1H), 7.09 (d, J = 10.3 Hz, 1H), 6.31 (s, 2H), 3.86 (s, 
3H), 3.72 (s, 6H). 13C NMR (101 MHz, Acetone-d6) δ 185.42, 178.43, 165.23, 159.93, 
106 
 
138.50, 135.94, 134.62, 91.91, 56.38, 56.02. HRMS (ESI-QTOF) calcd for C15H13NO7 
[M + H]+ 320.0765, found 320.0764. 
  
2',4',5'-trimethoxy-6-nitro-[1,1'-biphenyl]-2,5-dione. 1H NMR (600 MHz, 
Acetone-d6) δ 7.13 (d, J = 10.3 Hz, 1H), 7.08 (d, J = 10.2 Hz, 1H), 6.82 (s, 1H), 6.80 (s, 
1H), 3.90 (s, 3H), 3.74 (s, 3H), 3.73 (s, 3H). 13C NMR (151 MHz, Acetone-d6) δ 185.31, 
178.66, 154.14, 153.68, 144.22, 138.59, 135.81, 135.65, 115.11, 108.33, 98.84, 57.06, 
56.85, 56.40. HRMS (ESI-QTOF) calcd for C15H13NO7 [M + H]
+ 320.0765, found 
320.0764. 
  
2'-bromo-4',6'-dimethoxy-6-nitro-[1,1'-biphenyl]-2,5-dione. 1H NMR (400 
MHz, Acetone-d6) δ 7.22 (s, 1H), 6.88 (s, 1H), 6.69 (s, 1H), 3.88 (s, 3H), 3.79 (s, 3H). 
13C NMR (101 MHz, Acetone-d6) δ 184.90, 178.41, 164.11, 159.96, 138.34, 136.41, 
135.01, 123.94, 111.42, 110.49, 98.98, 56.90, 56.43. HRMS (ESI-QTOF) calcd for 
C14H11BrNO6 [M + H]




2-(5-methylfuran-2-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. 1H NMR (400 
MHz, Chloroform-d) δ 7.67 (dd, J = 3.7, 1.4 Hz, 1H), δ 6.84 (d, J = 1.5 Hz, 2H)., 6.37 – 
6.31 (m, 1H), 2.48 – 2.23 (m, 3H). 13C NMR (101 MHz, Chloroform-d) δ 184.54, 177.32, 
161.39, 140.91, 136.97, 135.05, 127.53, 120.51, 112.25, 14.34. HRMS (APCI-QTOF) 
calcd for C11H7NO5 [M + H]
+ 234.0397, found 234.0392. 
  
2-(5-ethylfuran-2-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. 1H NMR (600 
MHz, Acetone-d6) δ 7.65 (d, J = 3.7 Hz, 1H), 7.03 (d, J = 10.2 Hz, 1H), 6.99 (d, J = 10.2 
Hz, 1H), 6.52 (d, J = 3.7 Hz, 1H), 2.72 (q, J = 7.6 Hz, 2H), 1.21 (t, J = 7.6 Hz, 3H). 13C 
NMR (151 MHz, Acetone-d6) δ 185.34, 178.64, 166.41, 141.85, 138.41, 135.57, 127.06, 
127.05, 121.53, 111.31, 22.31, 12.09. HRMS (ESI-QTOF) calcd for C12H10NO5 [M + H]
+ 
248.0560, found 248.0546. 
  
2-(5-methylthiophen-2-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. 1H NMR 
(400 MHz, Acetone-d6) δ 7.33 (d, J = 4.0 Hz, 1H), 7.13 (d, J = 10.2 Hz, 1H), 7.05 (d, J = 
10.2 Hz, 1H), 7.00 (dd, J = 4.0, 1.0 Hz, 1H), 2.59 (s, 3H). 13C NMR (101 MHz, Acetone-
d6) δ 186.19, 178.48, 154.21, 138.28, 135.49, 134.83, 128.42, 127.57, 125.25, 15.52. 
HRMS (ESI-QTOF) calcd for C11H7NO4S [M - H]




2-nitro-3-(1H-pyrrol-2-yl)cyclohexa-2,5-diene-1,4-dione. 1H NMR (400 MHz, 
Acetone-d6) δ 11.43 (s, 1H), 7.46 (ddd, J = 3.5, 2.5, 1.3 Hz, 1H), 7.03 (d, J = 10.2 Hz, 
1H), 6.97 (d, J = 10.2 Hz, 1H), 6.75 (ddd, J = 4.1, 2.7, 1.3 Hz, 1H), 6.42 (dt, J = 4.4, 2.4 
Hz, 1H). 13C NMR (101 MHz, Acetone-d6) δ 189.04, 178.00, 138.19, 135.73, 130.46, 
123.46, 119.80, 119.58, 113.57, 113.53. HRMS (ESI-QTOF) calcd for C10H7N2O4 [M + 
H]+ 219.0410, found 219.0398. 
  
2-(2,5-dimethyl-1H-pyrrol-3-yl)-3-nitrobenzene-1,4-diol. 1H NMR (400 MHz, 
Chloroform-d) δ 8.96 (s, 1H), 7.94 (s, 1H), 7.16 (d, J = 9.1 Hz, 1H), 7.02 (d, J = 9.1 Hz, 
1H), 5.70 (dd, J = 2.8, 1.2 Hz, 1H), 5.56 (s, 1H), 2.26 (s, 3H), 2.03 (s, 3H). 13C NMR 
(101 MHz, Chloroform-d) δ 148.01, 147.44, 135.68, 128.21, 125.20, 122.51, 118.68, 
117.78, 109.11, 106.44, 13.20, 11.55. HRMS (ESI-QTOF) calcd for C12H12N2O4 [M]
- 




4'-(dimethylamino)-6-nitro-[1,1'-biphenyl]-2,5-dione. 1H NMR (400 MHz, 
Acetone-d6) δ 7.25 (d, J = 9.1 Hz, 2H), 7.07 (d, J = 9.9 Hz, 1H), 7.01 (d, J = 10.1 Hz, 1H), 
6.78 (d, J = 9.1 Hz, 2H), 3.06 (s, 6H). 13C NMR (101 MHz, Acetone-d6) δ 186.94, 
178.57, 153.44, 148.06, 138.48, 135.58, 135.47, 132.47, 115.04, 112.45, 40.08. HRMS 
(ESI-QTOF) calcd for C14H12N2O4 [M + H]
+ 273.0870, found 273.0867. 
 
2-(1-ethyl-1,2,3,4-tetrahydroquinolin-6-yl)-3-nitrocyclohexa-2,5-diene-1,4-
dione. 1H NMR (400 MHz, Acetone-d6) δ 7.08 (dd, J = 8.8, 2.4 Hz, 1H), 7.05 (d, J = 10.0 
Hz, 1H), 6.99 (d, J = 10.2 Hz, 1H), 6.96 (dd, J = 2.3, 1.3 Hz, 1H), 6.69 (d, J = 8.8 Hz, 1H), 
3.49 – 3.38 (m, 4H), 2.70 (t, J = 6.3 Hz, 2H), 1.98 – 1.88 (m, 2H), 1.16 (t, J = 7.1 Hz, 3H). 
13C NMR (101 MHz, Acetone-d6) δ 187.15, 178.37, 149.04, 147.38, 138.39, 135.57, 
135.43, 131.94, 131.25, 123.07, 114.51, 110.95, 49.27, 45.97, 22.33, 11.46. HRMS (ESI-
QTOF) calcd for C17H16N2O4 [M + H]
+ 313.1183, found 313.1184. 
  
2-(1-methylindolin-5-yl)-3-nitrocyclohexa-2,5-diene-1,4-dione. 1H NMR (400 
MHz, Acetone-d6) δ 7.11 (dd, J = 8.4, 1.9 Hz, 1H), 7.07 – 6.90 (m, 3H), 6.50 (dd, J = 8.4, 
1.4 Hz, 1H), 3.52 (d, J = 8.3 Hz, 2H), 2.98 (t, J = 8.4 Hz, 2H), 2.86 (s, 3H). 13C NMR 
(101 MHz, Acetone-d6) δ 186.04, 177.54, 156.02, 137.47, 134.98, 134.56, 131.44, 
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130.58, 128.77, 125.77, 125.51, 105.54, 54.57, 33.44, 27.39. HRMS (ESI-QTOF) calcd 
for C15H12N2O4 [M + H]
+ 285.0870, found 285.0871. 
  
2-methyl-4-nitrobenzofuran-5-ol. 1H NMR (400 MHz, Chloroform-d) δ 11.08 (s, 
1H), 7.59 (d, J = 8.9 Hz, 1H), 7.09 (s, 1H), 6.93 (d, J = 8.9 Hz, 1H), 2.51 (s, 3H). 13C 
NMR (101 MHz, Chloroform-d) δ 161.02, 153.78, 148.66, 125.38, 120.54, 113.79, 
104.70, 14.55. HRMS (ESI-QTOF) calcd for C9H6NO4 [M - H]
- 193.0300, found 
193.0288. 
  
4-nitro-2-phenylbenzofuran-5-ol. 1H NMR (400 MHz, Chloroform-d) δ 11.18 (s, 
1H), 7.95 – 7.87 (m, 2H), 7.77 – 7.69 (m, 2H), 7.49 (ddt, J = 8.2, 6.6, 1.2 Hz, 2H), 7.46 – 
7.40 (m, 1H), 7.02 (d, J = 9.0 Hz, 1H). 13C NMR (101 MHz, Chloroform-d) δ 160.64, 
154.26, 148.83, 130.10, 129.37, 129.26, 129.24, 129.20, 125.78, 125.65, 125.51, 121.00, 
115.01, 102.79. HRMS (ESI-QTOF) calcd for C14H8NO4 [M - H]





Tert-butyl((3,5-dimethoxybenzyl)oxy)dimethylsilane. To a solution of (3,5-
dimethoxyphenyl)methanol (841 mg, 5.0 mmol, 1.0 equiv.) and imidazole (447 mg, 6.5 
mmol, 1.3 equiv.) in 10 ml of dry DMF in ice bath, tert-butylchlorodimethylsilane (1130 
mg, 7.5 mmol, 1.5 equiv.) was added in a single portion. The mixture was allowed to 
warmed up to room temperature, and stirred for 16 hours. The reaction was quenched 
with saturated NaHCO3 solution, extracted with ethyl acetate three times, and washed 
with brine. The organic phase was separated then dried over Na2SO4. After removal of 
the solvent under vacuo, the crude material was purified by flash column chromatography, 
affording the TBS ether as a colorless oil (quantitative yield). 1H NMR (400 MHz, 
Chloroform-d) δ 6.51 (dt, J = 1.6, 0.7 Hz, 2H), 6.35 (t, J = 2.3 Hz, 1H), 4.70 (s, 2H), 3.79 
(s, 6H), 0.96 (s, 9H), 0.11 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 160.77, 144.06, 




nitro-[1,1'-biphenyl]-2,5-dione. Synthesized according to the general procedure of 
electron rich aromatics addition to nitroquinone in a 2 mmol scale. The crude was 
identified as a mixture of isomers in 4:1 ratio. 1H NMR (600 MHz, Chloroform-d) δ 7.00 
(d, J = 6.5 Hz, 1H), 6.98 (d, J = 6.4 Hz, 2H), 6.93 (d, J = 5.8 Hz, 2H), 6.92 (d, J = 5.8 Hz, 
1H), 6.58 (d, J = 0.9 Hz, 1H), 6.52 (d, J = 2.2 Hz, 2H), 6.38 (d, J = 2.3 Hz, 2H), 4.74 (d, J 
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= 0.9 Hz, 1H), 4.60 (d, J = 13.3 Hz, 2H), 4.52 (d, J = 13.4 Hz, 2H), 3.82 (s, 7H), 3.72 (s, 
4H), 3.71 (s, 7H), 0.96 (s, 5H), 0.86 (s, 19H), 0.12 (s, 3H), 0.01 (s, 7H), 0.00 (s, 7H). 13C 
NMR (101 MHz, Chloroform-d) δ 184.54, 177.53, 162.63, 158.26, 157.94, 147.74, 
142.68, 137.79, 137.66, 136.23, 134.86, 106.67, 104.24, 101.43, 97.48, 56.10, 56.01, 
55.59, 26.13, 26.09, 18.76, -5.10, -5.22, -5.25. HRMS (ESI-QTOF) calcd for C14H8NO4 




Step 1: To a solution of a mixture of 63 (220 mg, 0.5 mmol, 1.0 equiv.) in 5 mL 
of DCM at room temperature, (buta-1,3-dien-1-yloxy)trimethylsilane (108 mg, 0.75 
mmol, 1.5 equiv.) was added, and the solution was allowed to be stirred overnight. 
Solvents were removed under vacuo, and the crude adduct was taken in to the next step 
without further purification. The TMS ether intermediate was not stable at room 
temperature and OTMS group will eliminate to aromatize forming naphthohydroquinone 
spontaneously. HRMS (ESI-QTOF) calcd for C28H41NO8Si2 [M]




Step 2: To a solution of the TMS silyl ether (crude from step 1) in 13.5 mL of 
THF, 1.5 mL of 0.5M HCl solution was added. The mixture was stirred at room 
temperature for about 2 hours (monitored by TLC analysis), and then ethyl acetate was 
added. The reaction was extracted by ethyl acetate for three times, and washed with water 
followed by brine. The organic phase was separated and was dried over Na2SO4. 
Removal of ethyl acetate under vacuo provided the alcohol, which was taken into the 
next step immediately.  
Step 3: To a suspension of PCC (1.0 gram, excess) and NaOAc (241mg, excess) 
in 25 mL of DCM at room temperature, a solution of alcohol (crude from step 2) in 
another 25 mL of DCM was added dropwise. The mixture was allowed to stirred for 3 
hours then filtered through a silica pad. Solvent was removed under vacuo, and the crude 
material was loaded on a silica column chromatography. Eluted with ethyl acetate/hexane 
(1:4) afforded the product as a solid (76% yield over 3 steps). 1H NMR (600 MHz, 
Chloroform-d) δ 11.44 (s, 1H), 7.72 (s, 1H), 7.40 – 7.33 (m, 1H), 6.56 (d, J = 2.2 Hz, 1H), 
6.40 (d, J = 2.3 Hz, 1H), 4.64 (d, J = 13.4 Hz, 1H), 4.56 (d, J = 13.5 Hz, 1H), 3.83 (s, 3H), 
3.72 (s, 3H), 0.79 (s, 9H), -0.07 (s, 3H), -0.09 (s, 3H). 13C NMR (101 MHz, Chloroform-
d) δ 181.74, 180.74, 162.62, 162.09, 158.22, 151.38, 142.68, 139.55, 137.68, 131.87, 
125.33, 120.90, 114.09, 107.15, 104.09, 97.52, 64.31, 56.14, 55.61, 26.00, 18.67, -5.39, -
5.41. HRMS (ESI-QTOF) calcd for C25H30NO8Si [M]





hydroxynaphthalene-1,4-dione. To a solution of nitroquinone 66 (151 mg, 0.3 mmol, 
1.0 equiv.) with Pd/C (5 mg, catalytic) in 15 mL of methanol under argon, hydrogen gas 
was sparged through the solution via a long needle for 10 minutes. The mixture was 
stirred under hydrogen atmosphere overnight at room temperature. After the reaction is 
finished (monitored by TLC), excess amount of activated MnO2 powder was added, and 
the mixture was stirred for additional 20 minutes (similar yield can be achieved by 
stirring under air for 1-2 hours without addition of MnO2). The suspension was filtered 
through a silica pad, and concentrated under vacuo. Purification by column 
chromatography afforded the product as an orange solid (76% yield). 1H NMR (400 MHz, 
Chloroform-d) δ 11.64 (s, 1H), 7.64 (dd, J = 7.5, 1.4 Hz, 1H), 7.60 (t, J = 7.8 Hz, 1H), 
7.16 (dd, J = 8.2, 1.4 Hz, 1H), 6.84 (d, J = 2.5 Hz, 1H), 6.47 (d, J = 2.4 Hz, 1H), 4.96 (s, 
2H), 4.53 – 4.40 (m, 2H), 3.85 (s, 3H), 3.71 (s, 3H), 0.89 (s, 9H), 0.03 (s, 3H), 0.01 (s, 
3H). 13C NMR (101 MHz, cdcl3) δ 186.07, 180.90, 161.51, 161.48, 158.08, 146.12, 
143.21, 137.39, 133.58, 122.41, 119.42, 114.48, 113.68, 110.18, 103.79, 97.97, 63.04, 
56.06, 55.51, 26.09, 18.49, -5.13, -5.15. HRMS (ESI-QTOF) calcd for C25H31NO6Si [M 
+ H]+ 470.1993, found 470.2004. 
 
8-hydroxy-1,3-dimethoxy-5H-dibenzo[c,g]chromene-7,12-dione. A suspension 
of TBS ether 67 (25 mg, 0.053 mmol, 1.0 equiv.) in 2 mL of 30% H2SO4 was heated 
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under reflux for 2 hours. After the reaction is finished, the mixture was cooled to room 
temperature, then 20 mL of water was added. Extraction with ethyl acetate three times, 
and the organic phase was washed with brine, dried over Na2SO4. Solvents were removed 
under vacuo, and the crude material was purified by flash column chromatography using 
ethyl acetate/hexane (2:1). The cyclization product was obtained as a red solid (94% 
yield). 1H NMR (400 MHz, Chloroform-d) δ 11.79 (s, 1H), 7.67 – 7.51 (m, 2H), 7.19 (d, 
J = 7.3 Hz, 1H), 6.49 (s, 1H), 6.34 (s, 1H), 5.10 (s, 2H), 3.85 (s, 3H), 3.82 (s, 3H). 13C 
NMR (101 MHz, Chloroform-d) δ 183.95, 181.27, 163.27, 161.45, 157.90, 153.54, 
136.59, 135.04, 133.77, 127.07, 123.53, 119.19, 114.18, 108.60, 102.41, 99.69, 70.87, 
56.26, 55.83. HRMS (ESI-QTOF) calcd for C19H14O6 [M + H]




Step 1: To a solution of TBS ether 67 (15 mg, 0.03 mmol, 1.0 equiv.) in 1 mL of 
dry THF, a solution of 1M TBAF (0.06 mL, 0.06 mmol, 2.0 equiv.) in THF was added. 
The mixture was stirred at room temperature for 1 hour, and was quenched by addition of 
saturated NH4Cl solution. Extraction with ethyl acetate three times, and the organic phase 
was washed with brine, dried over Na2SO4. Solvent was removed under vacuo and the 
crude intermediate alcohol (as an orange solid) was taken into the next step without 
further purification.  
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Step 2: The orange solid from step 1 was dissolved in 3 mL of DCM at ambient 
temperature. Dess-Martin periodinane (excess amount) was added to the previous 
solution, and the mixture was stirred till the starting material 11 was fully reacted (MnO2 
will provide the same result in a much slower rate). Saturated NH4Cl solution was added, 
and the resulted solution was extracted with ethyl acetate three times, washed with brine. 
The separated organic phase was dried over Na2SO4. Solvents were removed under vacuo, 
and the product was purified by flash column chromatography (3:1 of DCM/ethyl acetate) 
(>99% yield). 1H NMR (400 MHz, Chloroform-d) δ 12.31 (s, 1H), 9.33 (s, 1H), 7.70 – 
7.63 (m, 1H), 7.61 (dd, J = 7.4, 1.3 Hz, 1H), 7.28 (dd, J = 8.2, 1.2 Hz, 1H), 6.98 (d, J = 
2.3 Hz, 1H), 6.91 (d, J = 2.3 Hz, 1H), 4.01 (s, 3H), 3.98 (s, 3H). 13C NMR (101 MHz, 
Chloroform-d) δ 187.13, 184.93, 162.86, 162.16, 158.22, 155.91, 143.23, 136.94, 136.41, 
133.85, 132.32, 123.49, 119.60, 118.63, 115.35, 105.82, 98.95, 56.56, 56.19. HRMS 
(ESI-QTOF) calcd for C19H13NO5 [M + H]
+ 336.0866, found 336.0867. 
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CHAPTER 3.    GENERAL CONCLUSION 
The transformations of the bio-privilege molecule – methyl coumalate was 
exclusively studied in the first chapter, especially by Diels-Alder reaction. Methyl 
coumalate was proved to be an excellent dienophile that could undergo Diels-Alder 
reaction with enamines, indole anions and hydroxyquinones. Under the proper reaction 
conditions, the corresponding products were isophthalates, naphthalates, hydrocarbazoles 
and naphthoquinones, respectively. Synthesis of an industrially important monomer 
dimethyl 2,7-naphthoate was achieved in kilogram scale, and the processes for 
purification of each step were developed. A short synthesis of the natural product 
tomichaedin was accomplished from commercially available materials. 
In the second chapter, we studied the transformation and functionalization of 
nitroquinone species. A wide range of nucleophiles showed good reactivity with the high 
active nitroquinone, and 3-substituted quinones were obtained in moderate yield. Dienes 
were able to react with the double bond on the 5,6-position of the nitroquinone, affording 
the naphthoquinones after oxidation. Benzofurans could also be synthesized via this 
strategy. In the end, we showed a synthesis route towards phenathroviridone and 
lagumycin skeleton. 
